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ABSTRACT 
 
Human immunodeficiency virus (HIV)-infected patients receiving antiretroviral treatment 
(ART) may develop metabolic syndrome and lipodystrophy, leading to obesity rather than 
wasting. Obesity is associated with metabolic homeostasis disruptions leading to pancreatic 
toxicity, diabetes, renal vasodilation and compression as well as liver steatosis. In addition, 
patients on long-term combination antiretroviral treatment (cART) can develop pancreatitis, 
nephrotoxicity, hepatic steatosis, and diabetes. This study aims to investigate the effects of 
cART combined with a high-calorie diet (HCD) on the histomorphometry of the pancreas, 
kidney, liver, and aortic perivascular adipose tissue (PVAT) leptin expression in the rat. Male 
Wistar rats (N=40) were divided into four groups (n=10); C/ART- (lean control), C/ART+ 
(ART control), HCD/ART- (HCD control) and HCD/ART+ (HCD and ART). The aorta with 
surrounding PVAT, pancreas, liver and kidney were harvested and processed to wax. Pancreas 
sections underwent a double immunohistochemistry (IHC) labelling for insulin and glucagon 
and reactive cell areas were measured. Aortic PVAT was labelled with anti-leptin and the 
staining intensity classified accordingly. Kidney sections underwent haematoxylin and eosin 
(H&E) stain measuring the areas of the renal corpuscles, glomeruli, renal spaces as well as the 
renal arcuate arteries lumen diameter and artery wall thickness. Pancreatic, kidney and liver 
sections underwent H&E staining which were used for pathology assessment. 
The HCD/ART+ had a significant body mass increase compared to the C/ART-, suggesting 
ART combined with a HCD causes body mass increase. Unilocular and differentiating 
adipocytes in the C/ART+ had intense leptin staining, suggesting ART may lead to increased 
leptin expression in aortic PVAT. Unilocular and differentiating adipocytes in the HCD/ART- 
and HCD/ART+ had weak to no leptin intensity, suggesting possible leptin deficiency with a 
HCD. The C/ART+ showed a trend in smaller total pancreatic islet area compared to the 
C/ART-, suggesting that islets underwent possible hypotrophy with ART. Based on the average 
values, alpha-cells were increased in the HCD/ART-, whereas beta-cells decreased in the ART 
and HCD. This suggests that a HCD potentially increases glucagon secreting area, whereas 
ART and a HCD leads to β-cell mass loss. The HCD/ART- and HCD/ART+ showed a trend in 
increased number of islets per section compared to the C/ART-, suggesting that HCD leads to 
new forming islets. Based on the average values, the renal corpuscle, glomeruli and renal space 
sizes were increased in the HCD/ART- compared to the other groups, although not 
significantly. A trend in the HCD/ART+ showed increased arcuate artery lumen diameter and 
tunica media thickness, whereas the C/ART+ had increased tunica adventitia compared to the 
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C/ART-. This suggests that ART combined with a HCD causes hypertrophic remodelling in 
the tunica media and hypotrophic remodelling in the tunica adventitia. All groups had mild 
vacuolisation and swelling of the proximal convoluted tubules in the kidney and granular 
appearance, vacuolisation, and fatty change in the liver. The six week cART and HCD used in 
the present study caused no significant morphometric or pathological changes within the 
pancreas, kidney, and liver, apart from significant leptin intensity staining with ART.  
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OPSOMMING 
 
Pasiënte wat met die menslike immuniteitsgebreksvirus (MIV) besmet is en antiretrovirale 
behandeling (ARB) ontvang, kan metaboliese sindroom en lipodistrofie ontwikkel, wat tot 
obesiteit eerder as uittering lei. Obesiteit word geassosieer met metaboliese homeostase-
versteurings, wat lei tot pankreas-toksisiteit, diabetes, renale vasodilatasie en kompressie asook 
lewersteatose. Hierbenewens kan pasiënte wat langtermyn-kombinasie- antiretrovirale 
behandeling (kARB) ontvang pankreatitis, nier-toksisiteit, hepatiese steatose en diabetes 
ontwikkel. Hierdie studie was daarop gemik om die histomorfometriese effekte van kARB 
gekombineer met ŉ hoëkalorie-dieet (HKD) op die pankreas, niere, lewer en leptienuitdrukking 
van die aorta-perivaskulêre adiposisweefsel (PVAW) in ŉ rotmodel te ondersoek.  
Manlike Wistar-rotte (N=40) is in vier groepe verdeel (n=10); K/ARB- (vetvrye beheergroep), 
K/ARB+ (ARB-beheergroep), HKD/ARB- (HKD-beheergroep) en HKD/ARB+ (HKD en 
ARB). Die aorta met omliggende PVAW, pankreas, lewer en niere is geoes en histologies 
voorberei. Pankreasdele het ŉ dubbele immunohistochemie- (IHC-)merking vir insulien en 
glukagon ondergaan en reaktiewe seldele is gemeet. Aorta-PVAW is gemerk met antileptien 
en die kleuringintensiteit is dienooreenkomstig geklassifiseer. Nierdele is gekleur met 
hematoksilien- en eosien (H&E-) en die renale liggaampies, glomeruli, renale ruimtes asook 
die renale arkuate arterielumendeursnee en arteriewanddikte is gemeet. Pankreas-, nier- en 
lewerdele word met H&E gekleur, wat vir patologie-assessering gebruik is. 
Die HKD/ARB+ het ŉ aanmerklike liggaamsmassatoename getoon in vergelyking met die 
K/ARB-, wat aan die hand doen dat ARB gekombineer met ŉ HKD liggaamsmassatoename 
veroorsaak. Unilokulêre en differensiërende adiposiete in die K/ARB+ het intense 
leptienkleuring getoon, wat aan dui dat ARB tot verhoogde leptienuitdrukking in aorta-PVAW 
kan lei. Unilokulêre en differensiërende adiposiete in die HKD/ARB- en HKD/ARB+ het swak 
tot geen leptienintensiteit getoon, wat op moontlike leptientekort met HKD kan dui. Die 
K/ARB+ het ŉ neiging tot kleiner totale pankreas-eilandoppervlakte in vergelyking met die 
K/ARB- getoon, wat aan dui dat eilande moontlike hipotrofie met ARB ondergaan het. Alfa-
selle het in die HKD/ARB- toegeneem, terwyl beta-selle in die ARB en HKD afgeneem het. 
Dit dui daarop dat ŉ HKD moontlik verhoogde alfa-sel area veroorsaak, terwyl ARB en ŉ HKD 
tot β-sel-massaverlies lei. Die HKD/ARB- en HKD/ARB+ het ŉ neiging getoon tot verhoogde 
aantal eilande per deel in vergelyking met die K/ARB-, wat aan die hand doen dat HKD tot die 
vorming van nuwe eilande lei. Renale liggaampies, glomeruli en renale ruimtegroottes is 
Stellenbosch University  https://scholar.sun.ac.za
 vi 
 
verhoog in die HKD/ARB- in vergelyking met die ander groepe, dog nie beduidend nie. ŉ 
Neiging in die HKD/ARB+ het verhoogde arkuate arterielumendeursnee en tunica mediadikte 
getoon, terwyl die K/ARB+ verhoogde tunica adventitia in vergelyking met die K/ARB- 
getoon het. Dit doen aan die hand dat ARB gekombineer met ŉ HKD hipertrofiese 
hermodellering in die tunica media en hipotrofiese hermodellering in die tunica adventitia 
veroorsaak. Alle groepe het matige vakuolisering en swelling van die proksimale kronkelbuise 
in die nier en granulêre voorkoms, vakuolisering en vetverandering in die lewer getoon. Die 
sesweek-kARB en HKD wat in die huidige studie gebruik is, het geen aanmerklike 
morfometriese of patologiese veranderinge in die pankreas, nier en lewer veroorsaak nie, buiten 
beduidende leptienintensiteitkleuring met ARB.  
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 1. INTRODUCTION 
 
 Implementation of combination antiretroviral treatment (cART) has been successful in 
reducing morbidity and mortality rates in human immunodeficiency virus (HIV) infected 
individuals, however treatment may lead to drug related toxicity. Currently obesity is often 
associated with HIV patients on antiretroviral treatment (ART) (Amorosa et al. 2005). In turn, 
obesity is associated with pancreatic toxicity (Slavin et al. 2010), liver fibrosis and steatosis 
(Goodman 2016), renal vasodilation and compression (Hall 2003), and altered adipocytokine 
expression from perivascular adipose tissue (PVAT) (Tsiodras and Mantzoros, 2006). In 
addition, ART shows increased toxicity within various organs and may cause diseases such as 
pancreatitis, nephrotoxicity, lactic acidosis, and hepatic steatosis (Cornejo-juárez et al. 2003).  
Pancreatic toxicity is a side effect of ART which may lead to pancreatitis, steatosis, islet alpha 
(α)- and beta (β)-cells dysfunction (Elfane et al. 2016; Adler et al. 1987). Furthermore, obesity 
is associated with pancreatic islet alterations such as increased islet number, size, and insulin 
secretion (Slavin et al. 2010).  
In the kidney glomerular enlargement and renal toxicity which causes kidney injury is seen in 
HIV-patients on ART (Fabian et al. 2013; Jao & Wyatt 2016), while in obese patients renal 
vasodilation and renal medullary compression have been reported histologically (Hall 2003).  
The most common liver diseases seen with the onset of obesity and ART are chronic hepatitis, 
liver steatosis and the development of liver cirrhosis from liver fibrosis (Yamauchi & 
Michitaka 1998; Grinspoon & Carr 2005; Neuman et al. 2012).  
Adequate adipocytokine levels, such as leptin, are required to maintain normal metabolic 
homeostasis in the body (Lago et al. 2009). In obesity, leptin expression is up regulated in 
perivascular adipose tissue (PVAT) which in turn may cause elevated arterial pressure and 
hypertension (Shek et al. 1998). Furthermore, ART causes increased circulating leptin (Jan et 
al. 2004; Lagathu et al. 2005). 
The present study aims to investigate the histomorphological effects of the first line cART 
(Odimune) used in South Africa in conjunction with a high-calorie diet (HCD) on the 
pancreatic islets, kidney renal corpuscle and arcuate artery, liver tissue and aortic PVAT leptin 
stain intensity in a rat model. The Wistar rat strain is a suitable model used in the present study 
and is one of the most popular rats used in laboratory research. This strain is bred for biological 
and medical research, whereas Zucker rats are bred to be a genetic model on obesity and 
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hypertension. As the aim of the present study was to determine the effects of a high-calorie diet 
(HCD) and ART on various organs, a wild type train was needed. The results of the study will 
provide information on the histological changes with the use of this specific cART (Odimune) 
in combination with a high-calorie diet, as is suggested by observational studies and case 
reports. Therefore this study may provide a basis for future research and development into 
obesity caused by ART increasing research output in South Africa. 
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2. LITERATURE REVIEW 
 
2.1. Human immunodeficiency virus (HIV), antiretroviral treatment (ART) and 
obesity 
 
In 2016, the United Nations Programme on human immunodeficiency (HIV)/ acquired 
immunodeficiency syndrome (UNAIDS) estimated worldwide 36.7 million individuals (adults 
and children) are HIV-infected (UNAIDS 2017). Currently in South Africa there are 7.1 million 
HIV-infected individuals (UNAIDS 2017). HIV targets a host cell, which the virus uses to 
multiply by fusing with the CD4 receptors and then enters the RNA strands to convert to DNA. 
The virus binds to various types of cells, such as CD4 lymphocytes (T cells), monocytes, 
macrophages and other white blood cells  (Arts et al. 2012). Antiretroviral treatment (ART) 
disrupts the reproduction cycle of the virus, by inhibiting the viral enzyme. There are five 
commonly used antiretroviral treatments (ART) namely; Nucleoside reverse transcriptase 
inhibitors (NRTIs), Non-nucleoside reverse transcriptase inhibitors (NNRTIs), Protease 
inhibitors (PIs), Entry inhibitors and Integrase inhibitors. Different combinations of these 
treatments are known as highly active anti-retroviral treatment (HAART) (Arts et al. 2012). 
The NRTIs prevent viral reproduction and DNA elongation, their presence inhibits viral DNA 
replication. However, the NRTIs can function as substrates for other enzymes which are 
capable of DNA formation, such as mitochondrial DNA replication, which in turn could lead 
to mitochondrial disruption (Montessori et al. 2004).  
 
HIV-infected individuals in South Africa receive a first line regimen of cART, called Odimune 
a generic version of Atripla®, consisting of a combination of Tenofovir Disoproxil Fumarate 
or TDF (a nucleoside reverse transcriptase inhibitor), Emtricitabine or FTC (nucleoside reverse 
transcriptase inhibitor) and Efavirenz or EFV (non-nucleoside reverse transcriptase inhibitors) 
(South African National Department of Health 2015). Odimune is administered orally, one 
tablet on a daily basis. Efavirenz is mostly bound to human plasma proteins, whereas 
Emtricitabine and Tenofovir are minimally bound (Frampton & Croom 2006). With the use of 
ART the mortality and morbidity has declined among HIV-infected patients, cART are more 
beneficial to the HIV-infected patients than single treatment (Palella et al. 1998). 
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Disorders associated with HIV/AIDS are the wasting syndrome and peripheral lipoatrophy, 
which both decrease with the use of ART, however in some HIV-infected patients receiving 
ART both the wasting syndrome and peripheral lipoatrophy can still occur (Longenecker et al., 
2013; Wanke et al., 2015). Different combinations of ART and ART on its own can lead to a 
wide variety of adverse effects in the human body such as, gastrointestinal effects (nausea, 
diarrhoea, and bloating), fatigue, headaches, anaemia, hyperglycaemia, fat maldistribution, and 
hyperlipidaemia (Montessori et al. 2004; Dando & Wagstaff 2004). Combination ART can 
lead to various types of cellular adverse drug reactions (ADR), which include 
hepatocytotoxicity, lipodystrophy, type 2 diabetes mellitus (T2DM), hyperlipidaemia, 
nephrotoxicity (Carr et al. 2000; Neuman et al. 2012; Jain et al. 2001; Hawkins 2010). High 
levels of high-density lipoprotein (HDL) and triglycerides are seen in HIV-infected patients, 
with the use of ART the HDL and triglyceride levels increase even more (Pinto Neto et al. 
2013). Crum-cianflone et al. (2008) described the prevalence of obesity associated with HIV-
infected individuals before the use of ART and an increase in obesity with the use of ART. 
This suggested that the weight gained were associated with the general population and were 
unrelated to HIV or ART.   
 
Individuals are classified as being obese when their body mass index (BMI) is greater than 
30kg/m² (Achike et al. 2011; Balistreri et al. 2010). Obesity can be defined as imbalances 
between energy being stored and used and is associated with metabolic syndrome (Ogden et 
al. 2007). Obesity it is associated with metabolic homeostasis disruptions, over-nutrition and 
stress which links to visceral obesity (Karalis et al. 2009). Metabolic homeostasis disruptions 
caused by obesity often lead to lipodystrophy, hyperlipidaemia, hypertension, cardiovascular 
diseases (CVD), diabetes mellitus and non-alcoholic fatty liver disease (NAFLD) (Guzik et al. 
2006; Pi-Sunyer 2002; Van der Merwe & Pepper 2006; Shah, P. Alio, et al. 2012; Achike et 
al. 2011). Both ART and obesity causes metabolic syndrome, leading to obesity-induced 
hypertension and development of T2DM, adipose tissue distribution, increased triglycerides 
(dyslipidaemia), insulin resistance and impaired glucose tolerance, NAFLD, hepatic steatosis, 
renal diseases (Ogden et al. 2007; Rea et al. 2006; John et al. 1998; Lagathu et al. 2005) 
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2.2. Leptin expression in aortic perivascular adipose tissue (PVAT), with 
antiretroviral treatment and obesity 
 
Adipose tissue surrounding large arteries, such as the aorta, is known as perivascular adipose 
tissue (PVAT) (Schlett et al. 2009). PVAT is located on the outside of the tunica adventitia to 
which it adheres. It consist of mainly brown adipose tissue (BAT), while white adipose tissue 
(WAT) is found on the periphery and mixture of BAT and WAT, known as intermingled 
adipose tissue (Szasz et al. 2013). White adipose tissue is considered to be a source of free fatty 
acids (FFA) which are used as an energy substrate for the generation of adenosine triphosphate 
(ATP), providing energy for the organism during periods of fasting (Fain, Madan, Hiler, 
Cheema & Bahouth. 2015). Brown adipose tissue makes use of FFA to produce heat, which 
gives it a non-shivering thermogenesis function that assists in cold adaptions (Cannon & 
Nedergaard 2004; Raucci et al. 2013). Intermingled adipose tissue can also be described as 
differentiating adipocytes, due to the ability of WAT and BAT to transdifferentiate into one 
another, allowing the cells to participate in different energy demands (Cinti 1999). Adipose 
transformation is brought on by a physiological stimuli, such as growth of the rodent or human 
or with cold and heat exposure (Cousin et al. 1992). With cold exposure the WAT phenotype 
will differentiate into a BAT phenotype, whereas with warm exposure the BAT will change 
into WAT. This leads to the theory that newly formed brown adipocytes may be derived from 
stem cells migrating, or from differentiated white cells or a combination of the two (Cinti 
2009). In genetic and diet-induced obese animals the white adipocytes develops within brown 
adipose tissue areas (Cinti 1999).  
  
PVAT not only supports the arteries, but is considered to be metabolically active by secreting 
a variety of adipocytokines, such as adiponectin and leptin  (Guzik et al. 2006; Szasz et al. 
2013). Therefore PVAT can be classified as an endocrine organ, which effects the arteries it 
adheres to (Halberg et al. 2009; Szasz et al. 2013). Adiponectin is an adipocyte specific 
hormone and decreases with the onset of obesity (Arita et al. 1999; Guzik et al. 2006). Leptin 
regulates appetite via hypothalamic leptin-receptor signalling (Raucci et al. 2013). Leptin 
secretion is controversial as some studies suggest that it is expressed in both WAT and BAT 
(Moinat et al. 1995; Maffei et al. 1995), while other researchers maintain that leptin is 
expressed by WAT only and that the expression in BAT may be due to the presence of white 
adipocytes intermingled with BAT (Cancello et al. 1998; Cinti et al. 1997). A study done by 
Cinti et al. (1997) suggested that adipocytes at the multilocular stage of differentiation within 
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WAT depots were leptin-positive, suggesting that leptin is secreted by all lipid-containing cells 
found in adipose tissue. Leptin expression has been seen to decrease endothelium-dependant 
vasodilation, suggesting it plays a role in vascular dilation changes which causes blood pressure 
changes (Nakagawa et al. 2002; Payne et al. 2010; Rahmouni & Haynes 2005).  
 
Adequate adipose tissue and adipocytokine levels are required to maintain normal metabolic 
homeostasis in the body (Lago et al. 2009). Increased calorie intake causes adipose tissue mass 
increase which alters adipocytokine secretion from adipocytes in adipose tissue (Halberg et al. 
2009; Weisberg et al. 2003). Adipocytokines are increased with obesity which influence 
vasculature by endothelial dysfunction, vascular stiffness and smooth muscle migration (Payne 
et al. 2010; Montani et al. 2004). Altered adipocytokine levels, such as decreasing adiponectin 
and increasing leptin, are associated with both obesity and HIV-infected individuals receiving 
ART (Vlasova et al. 2010; Tsiodras & Mantzoros 2006). Circulating leptin levels are 
proportional to adipose tissue, therefore hyperleptinemia is associated with obesity 
(Giovannucci & Michaud 2007; Szasz et al. 2013). As previously mentioned leptin has a 
vasodilatory effect and is therefore associated with leptin resistance in obesity. Long term 
exposure to leptin secretion, due to a chronic obese state, leads hypertension and endothelial 
dysfunction (Shek et al. 1998). It has been suggested that adipocytokines are the molecular link 
between obesity and cardiovascular disease. The exact relationship between the two is not fully 
understood and there is still uncertainty concerning this association (Payne et al. 2010). 
 
2.3. Pancreas structure, antiretroviral treatment toxicity and obesity 
 
Observational studies have indicated that with obesity and the introduction of ART patients are 
insulin sensitive and glucose tolerant (Jain et al. 2001; Donath et al. 2013)  
The pancreas in both humans and rodents is a large gland consisting of endocrine and exocrine 
pancreas (Kierszenbaum 2007). The exocrine pancreas consist of acinar cells, duct cells, 
vessels and nerves and its main function is to secrete digestive enzymes. The endocrine 
pancreas represents approximately 2% of the total pancreas organ, consisting of pancreatic 
islets (islets of Langerhans) which regulates glucose metabolism via insulin-, glucagon-, 
somatostatin-, and pancreatic polypeptide secreting cells (Motta et al. 1997). In rats, the 
pancreas is divided into a splenic and duodenal region (Dolensek et al. 2015). The exocrine 
pancreas is covered by a thin layer of connective tissue, which extends into septa which divides 
the gland into lobules (Motta et al. 1997). The functional component of the exocrine pancreas 
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is the acinus which are commonly labelled as centroacinar cells (Kierszenbaum 2007). The 
acinar cells are arranged to form convoluted tubuloacinar network within the lobules (Haschek 
et al. 2010). Haematoxylin and Eosin (H&E) stain the acinar cells blue at their base due to high 
concentrations of RNA and nuclei, whereas the apex will stain pink due to high concentrations 
of zymogen proteins (Longnecker 2014).  
 
The endocrine pancreas, as mentioned previously, consist of pancreatic islets of varying sizes, 
ranging from 50-250 μm in diameter (Hellman 1959). Each islet is made up different cells and 
secretes peptide specific hormones, such as beta (β)-cells (insulin), alpha (α)-cells (glucagon), 
PP-cells (pancreatic polypeptide), and delta (δ)-cells (somatostatin) (Figure 2.1) (Longnecker 
2014; Dolensek et al. 2015)  
 
 
(Adapted from Dolensek et al. 2015) 
Figure 2.1 Pancreatic islet, with alpha (α) cells (pink), beta (β) cells (orange), delta cells 
(beige) and capillaries (red) in a rat. Peptide hormones secreted from each pancreatic 
islet include glucagon (α-cells, 15% of islet), insulin (β-cells, 75-80% of islet), pancreatic 
polypeptides (PP-cells, less than 5% of islet), and somatostatin (δ, 5% of islet)-cells. 
 
The endocrine cell arrangement in human islets are different compared to that of rodent islets 
(Dolensek et al. 2015). In rodents the β-cells make up the core of each islet, whereas the other 
cells (α-cells, δ-cells, and PP-cells) are on the mantle of the islets (Figure 2.1) (Dolensek et al. 
2015). The human islet structure is more complicated compared to rodents, where the islet cells 
are organized into a trilaminar plate. This plate consist of one layer of β-cells which are covered 
by two layers of  α-cells (Figure 2.2) (Bosco et al. 2010). When comparing the human islet to 
that of other species, such as the rodent islets, the human islets generally have smaller fraction 
of  β-cells (Steiner et al. 2010). 
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(Adapted from Bosco et al. 2010) 
Figure 2.2 Pancreatic islet structure in a human islet. The black cells represent the α-cell 
(glucagon) layer and the blue cells are the β-cell (insulin) layer, forming the trilaminar 
plate.  
 
Glucagon is secreted from the islet when blood glucose levels are decreased. Glucagon targets 
the liver which increases hepatic glucose production and therfore stimulates glycogenolysis 
and gluconeogenesis (Sherwood 2010). When the blood glucose levels are increased after a 
meal, the islet secretes insulin, which will allows glucose to be absorbed by insulin dependant 
tissue (Matschinsky & Ellerman 1967). Insulin is the main anabolic hormone in the body and 
regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of 
glucose, forming a feedback system between insulin and glucagon, which maintains  normal 
blood glucose levels in the body (Sherwood 2010).  
 
It is suggested that alterations in the pancreas in HIV-infected patients may be due to causes 
unrelated to the virus. These causes include; alcoholism, hyperlipidaemia, hypercalcaemia, 
adenocarcinoma, opportunistic infections, and ART (Cappell 1997). Antiretroviral treatment 
causes pancreatic toxicity in humans which leads to pancreatitis, steatosis (fat infiltration), islet 
hypertrophy and α- and β-cells dysfunction (changes in cell mass, phenotype and function), 
therefore causing insulin resistance and diabetes mellitus (Barbosa et al., 2013). Protease 
inhibitors induce insulin resistance by reducing glucose transportation (Grinspoon & Carr 
2005). Nucleoside reverse transcriptase inhibitors causes an increase in serum pancreatic 
enzymes, which leads to acute pancreatitis (Manfredi & Calza 2008). ART leads to acute 
pancreatitis, which is an inflammatory condition of the pancreas and is characterised by 
increased levels of pancreatic enzymes, acute inflammation and necrosis of pancreas 
parenchyma (Neuman et al. 2012).  
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Furthermore, the metabolic disruptions associated with obesity may lead to pancreas tissue 
inflammation, such as insulin resistance and type 2 diabetes mellitus (Donath et al. 2013; 
Savini et al. 2013). Obese individuals consume large amounts of carbohydrates causing 
elevated glucose levels which can be defined as impaired glucose tolerance, which in turn leads 
to hyperglycaemia (Donath et al. 2013). Type 2 diabetes mellitus is characterised by 
hyperglycaemia and dyslipidaemia (abnormal amount of lipids in the blood), causing islet 
dysfunction and insulin resistance (Nolan et al. 2011; Slavin et al. 2010). Hyperglycaemia 
induces beta-cell apoptosis thus causing an inflammatory process (Donath et al. 1999). The β-
cells in the pancreatic islets still produce insulin, although the peripheral body tissue becomes 
resistant to the insulin (Tushuizen et al. 2007). The decline in β-cell mass and apoptosis is due 
to various mechanisms of which a few include toxic metabolites and increased oxidative stress 
(Shimabukuro et al. 1998; Bryan et al. 2013). Obesity in both human and rodents are associated 
with pancreatic islet morphology alterations such as increased islet number, size, and insulin 
secretion (Slavin et al. 2010). 
 
2.4. Kidney structure, antiretroviral treatment toxicity and obesity 
 
Both obesity and ART may cause renal diseases, such as nephrotoxicity and glomerular 
sclerosis (Kasiske & Napier 1985; Karras et al. 2003). 
Each kidney in the human and rodent body consists of a cortex (outside) and a medulla (inside). 
The medulla (divided into the outer medulla and inner medulla) has pyramid structures, which 
are separated from each other by the cortex (Figure 2.3).  
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Figure 2.3 Annotated sketch indicating the kidney cut longitudinally, showing the cortex 
and medulla. 
The base of the medullary pyramids are located in the corticomedullary junction, and forms 
the renal lobe. The renal lobe base is the renal capsule, with the renal lobes’ lateral borders 
forming the renal columns (Kierszenbaum 2007; Young et al. 2006). The cortex (divided into 
the outer cortex and juxtamedullary cortex) forms a smooth outer layer and extends between 
the pyramids of the medulla, which contains the renal corpuscles. The glomerulus along with 
the capsule of Bowman forms the renal corpuscle (Silverthorn 2013; Kierszenbaum 2007). The 
function of the renal portal system is to filter fluids from the blood and into the glomerular 
capillaries to produce urine, which is composed of waste and extra fluid (Silverthorn 2013). 
Blood to the kidneys are supplied by the renal arteries, which branch into the interlobar arteries. 
The blood flows from the interlobar arteries into the arcuate arteries (located on the border of 
the cortex and medulla), which give off the interlobular arteries which penetrate the cortex to 
supply blood to the glomerular capillaries to be filtered (Kierszenbaum 2007; Young et al. 
2006). The glomerular capillary network is formed from the afferent arterioles and is encased 
by the capsule of Bowman, which leads to the efferent glomerular arterioles. This network of 
arterioles and capillaries are called the glomerulus (Figure 2.4). Another function of the 
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kidneys are to regulate blood pressure via the renin-angiotensinogen system, which is activated 
with an increase and decrease in blood pressure (Marieb & Hoehn 2006). 
 
 
(Adapted from Kierszenbaum 2007) 
Figure 2.4 Renal corpuscle which consist of the glomerular capsule. The glomerular 
capillary network is formed by the afferent and efferent arterioles (pink), filtering small 
molecules from the blood plasma. 
 
Long term exposure to ART is associated with significant renal toxicity (nephrotoxicity), which 
may cause kidney injury (Jao and Wyatt, 2016; Menezes et al., 2011). High doses of Tenofovir 
had histopathological effects such as kidney disease (nephropathy) and/or tubular dysfunction 
(Karras et al., 2003). Emtricitabine causes no nephrotoxicity, whereas Efavirenz causes 
minimal acute renal disease (Jao & Wyatt 2016). A recent study by Fabian et al. (2013) on the 
effects of pre-ART, seven month ART and 25 months ART on the histology of the kidney 
indicated that at seven months ART caused mild glomerular enlargement, dilated tubules and 
mesangial hyperplasia. Although at 25 months ART no glomerular enlargement and no 
mesangial alterations were observed in humans.  
 
A review article by Hall (2003) described that in obese individuals increased adipose tissue 
encapsulates the kidneys, which penetrates the medulla and causes compression, increased 
arterial pressures and renal-pressure natriuresis. Excessive weight gain increases renal tubular 
reabsorption and impairs natriuresis (Excretion of sodium in the urine via the kidneys). This 
can happen via the renin-angiotensin system and compression of the kidneys (Figure 2.5) (Hall 
2003). Changes occurring in the kidney due to obesity may cause compensatory mechanisms 
which leads to increased glomerular wall tension and glomerular hypertrophy. These 
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glomerular changes reduce the filtration surface area which in turn leads to increased blood 
pressure (Hall et al. 2014).  
 
 
(Adapted from Hall 2003) 
Figure 2.5 Obesity causes renal medullary compression, which leads to tubular 
reabsorption which in turn causes renal vasodilation and arterial hypertension.  
 
Increased glomerular filtration rate is seen with diabetes, which is caused by a reduction in the 
renal vascular resistance and glomerular capillary hypertension (Hostetter et al. 1981). In a 
study by De Vriese et al. (2001), diabetic rats indicated vasodilation in all pre-glomerular and 
post-glomerular arterial vessels. Renal compression could explain the relationship between 
abdominal obesity and hypertension (Hall 2003). With hypertension, arteries undergo 
eutrophic and/or hypertrophic remodelling. Eutrophic remodelling is the decrease of the 
luminal space without changes to the vessel wall (Jacobsen & Holstein-Rathlou 2010). 
Hypertrophic remodelling is seen when the vascular wall thickens due to hyperplasia which in 
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turn  increases the wall-to-lumen ration (Mulvany et al. 1996). Other causes of vascular 
thickening are intimal hyperplasia, vascular smooth muscle cells (VSMC) migration and 
proliferation (Safar et al. 1998). Some factors that have contributed to arterial remodelling 
includes; inflammation, apoptosis, fibrosis, and growth (Lu et al. 2011). Inflammatory cells 
increase in the tunica adventitia with hypertension (Intengan & Schiffrin 1993).  
 
2.5. Liver structure, antiretroviral treatment toxicity and obesity 
 
Hepatic steatosis and fibrosis is seen in obese individuals (Ratziu et al. 2000), whereas ART 
leads to hepatocytotoxicity effects, such as hepatitis, steatosis, and hepatocellular damage 
(Zimmerman 1978). The liver plays a role in fat, carbohydrates, and protein metabolism by 
storing metabolites, protein synthesis, and detoxify and secrete bile (Akiyoshi & Inoue 2012; 
Young et al. 2006). The liver is surrounded by a capsule containing collagen-elastic fibre 
(Kierszenbaum 2007). The functional unit of the liver is the hepatic lobules, consisting of 
hepatocytes and sinusoids, where the hepatocytes are arranged into irregular columns between 
the sinusoids (Akiyoshi & Inoue 2012). Each hepatocyte contains one round nucleus or 
sometimes two round nuclei (Silverthorn 2013). A distinctive component of the hepatic lobules 
are the portal triads, found in the portal spaces between the hepatic lobules and contains the 
portal vein, hepatic artery, bile duct, and lymph vessels (Young et al. 2006). The portal vein 
transports blood from other organs such as the spleen, pancreas and digestive tract, whereas 
the hepatic artery is branched from the celiac trunk and supplies the liver through the interlobar 
and interlobular artery (Kierszenbaum 2007).  
 
The most common liver diseases with the onset of obesity and ART are chronic hepatitis, liver 
steatosis which leads to the development of liver cirrhosis from liver fibrosis (Yamauchi & 
Michitaka 1998). Most obese or diabetic individuals have liver disease, which is not due to 
alcohol consumption (Adler & Schaffner 1979). This led to the term non-alcoholic fatty liver 
disease (NAFLD), previously non-alcoholic steatohepatitis (NASH), being used to define liver 
steatosis in obese or diabetic individuals. Although obesity plays an important role in NAFLD, 
the metabolic syndrome and insulin resistance are very important in the pathology of the liver 
(Day 2002). With the role of lipid metabolism in the liver, it is possible that lipids may 
accumulate in the liver, specifically in the hepatocytes, when there is an imbalance between 
the fat delivery into the liver and the transfer out of fat as very-low-density lipoproteins 
(VLDL) (Goodman 2016). In conditions such as metabolic imbalances, stress, and cellular 
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injury, lipid droplets become larger and therefore be visible under a light microscope. These 
lipid droplets are seen as vacuoles in the cytoplasm of the hepatocytes (Goodman 2016).  
 
ART interferes with liver mitochondrial metabolism, which may lead to lipid accumulation, 
because of oxidizing fatty acids. Therefore, hepatic steatosis in patients receiving ART, can be 
a sign of early mitochondrial dysfunction (Cornejo-juárez et al., 2003). ART has been reported 
to cause chronic hepatitis and portal hypertension (Neuman et al. 2012).  In addition, NRTIs 
used in ART is seen to be associated with hepatic steatosis (Grinspoon & Carr 2005). 
 
The effects of cART and accompanying obesity causes structural perturbations on the pancreas, 
kidney, liver and aortic PVAT and more extensive research is needed. The results of the study 
will provide information on the histological effects of cART combined with a high-calorie diet 
and be a basis for future research and development into obesity caused by ART. Although ART 
has changed the health care of HIV infected individuals, the adverse effects of the therapy may 
cause symptoms affecting various organ systems. Clinicians must concentrate on preventing 
these adverse drug effects if possible. As ART continues to develop, physicians treating HIV 
infected patients should remain aware of new and developing syndromes associated with the 
use of ART. 
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3. PROBLEM STATEMENT 
 
HIV/AIDS is associated with disorders such as wasting syndrome and peripheral lipoatrophy. 
Both of these conditions have decreased with the use of ART, although in some patients on 
ART both syndromes can still occur (Longenecker et al., 2013; Wanke et al., 2015). The ART 
era showed increases in toxicity within organs and leads to some diseases, such as peripheral 
neuropathy, myopathy, pancreatitis, nephrotoxicity, lactic acidosis, and hepatic steatosis 
(Cornejo-juárez et al. 2003; Elfane et al. 2016; Jao & Wyatt 2016; Neuman et al. 2012). Kidney 
lesions associated with HIV-infection has been studied extensively, however HIV-associated 
nephropathy (HIVAN) with patients on ARV treatment has not been investigated on 
histological level and knowledge regarding this is still limited (Fabian et al. 2013). Studies 
have suggested that HIV-infected individuals on ART become overweight and/or obese (Pinto 
Neto et al. 2013). Obesity is associated with various diseases, such as hyperlipidaemia, 
cardiovascular diseases (CVD), coronary heart disease, hypertension, and diabetes (Van Der 
Merwe & Pepper 2006; Pi-Sunyer 2002). The present study aims to investigate and determine 
the effects of obesity and ART in the morphological changes of the in the pancreatic islets-, 
the glomerular and arcuate artery changes in the kidney, and the portal tract changes in the 
liver. 
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4. AIMS AND OBJECTIVES 
 
4.1. Aim 
 
The aim of the study is to compare the histomorphometric effects of antiretroviral treatment 
(ART) in combination with a high-calorie diet (HCD) on the pancreas, liver, kidneys and leptin 
expression in aortic perivascular adipose tissue (PVAT) in the rat. 
 
4.2. Hypothesis 
 
Null hypothesis (H₀): There are no significant histomorphometric differences in the pancreas, 
kidney, liver and leptin expression in aortic PVAT between the four experimental groups. 
 
Hypothesis (Hₐ): There are significant histomorphometric differences in the pancreas, kidney, 
liver and leptin expression in aortic PVAT between the four experimental groups. 
 
4.3. Objectives 
 
Histochemical, immunohistochemical morphometric analysis of the four groups will be 
compared:  
1. Surface area (μm²) measurements will be used to compare the size of pancreatic islet area, 
while the area (μm²) of insulin and glucagon reactive cells will be compared to assess 
pancreatic histomorphology changes between lean, antiretroviral treated and high-calorie diet 
groups. 
2. The area (μm²), diameter (μm) and perimeter (μm) measurements of the renal corpuscle, 
glomeruli and renal space, with additional arcuate artery lumen diameter (μm) and artery wall 
thickness (μm) measurements will be compared to indicate possible glomerular and artery 
histomorphometry changes between lean, antiretroviral treated and high-calorie diet groups. 
4. Leptin stain intensity by unilocular and differentiating adipocytes in aortic PVAT will be 
compared between lean, antiretroviral treated and high-calorie diet groups. 
5. Pancreatic, renal and liver pathology will be compared between lean, antiretroviral treated 
and high-calorie diet groups in conjunction with a histopathologist and a histologist. This will 
be done to assess signs of possible toxicity of the organs other than morphometry differences. 
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5. STUDY DESIGN 
 
5.1. Ethical Clearance 
 
The Research Ethics Committee: Animal Care and Use of Stellenbosch University permitted 
ethical clearance for the Medical Physiology Division in the Department of Biomedical 
Sciences to euthanize and remove the hearts from male Wistar rats for the present study. 
Furthermore, ethical clearance was obtained for the use of various other organ tissues for 
histological purposes from the same animals (SU-ACUM13-00025).  
 
5.2. Animals 
 
Male Wistar rats (N=40) (eight weeks of age) were housed and cared for at the animal care 
facility of Stellenbosch University, Faculty of Medicine and Health Sciences. Animal care 
throughout the study conformed to the standards for animal use in research as reflected in the 
South African National Standards document (SANS 10386: 2008, available at 
www.sun.ac.za/research) of the South African Bureau of Standards (SABS). Animals were 
housed in cages and subjected to a controlled environment of ±22°C and 40% humidity on a 
12 hour artificial day/night cycle. Animals were randomly divided into four groups 
(n=10/group) as follows in (Figure 5.1). 
 
 
Figure 5.1 Classification of groups and sample sizes. Total Wistar rats (N=40) were 
divided into four groups (n=10); a lean control, a lean antiretroviral treatment (ART) 
treated, a high-calorie diet and a high-calorie diet drug treated, each group consisting of 
10 Wistar rats. 
N: Sample size; C: Lean control; HCD: High-calorie diet; ART-: No antiretroviral drug 
treatment (untreated); ART+; antiretroviral drug treated. 
Wistar rats
N=40
Lean control 
(C/ART-)
n=10
Lean drug treated  
(C/ART+)
n=10
High-calorie diet 
(HCD/ART-)
n=10
High-calorie diet Drug 
treated  (HCD/ART+)
n=10
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5.3. Feeding Programme and Drug Treatment 
 
5.3.1. Feeding Programme 
 
Animals (Initial weight: 224 gram) were placed on a 16-week feeding program, following an 
ad libitum diet (Appendix A). The HCD groups (HCD/ART- and HCD/ART+) only had free 
access to high-calorie food, consisting of 11.5% fat, 8.3% protein, 42% carbohydrates, and 
20% sucrose (Appendix B). The HCD food was prepared by soaking normal rat chow (600g) 
in 250 ml mixture of warm water and dissolved sucrose (140g sugar) for 10 min. The soaked 
rat chow was crushed and melted vegetable fat (4 x 125g Holsum™) and eight cans of full 
cream, sweetened, condensed milk (8 x 385 g/can, Clover™) were added. The mixture was 
then well mixed and stored in a refrigerator for use. Each individual animal was weighed and 
monitored for visible changes in their health. Food and water consumption were monitored 
daily and total body mass (TBM) of all animals were monitored and recorded weekly.  
 
5.3.2. Antiretroviral treatment (ART) 
 
At week 10 of the feeding programme the ART commenced and continued for the remaining 
six weeks. The ART groups (C/ART+ and HCD/ART+) received first line ART of South 
Africa, Odimune, which consists of 200 mg Emtricitabine (FTC), 300 mg Tenofovir Disoproxil 
fumarate (TDF), and 600 mg Efavirenz (EFV) for an average human (70 kg) (Appendix C). 
The dosage of drugs was calculated according to the average total body mass (TBM) recorded 
weekly for each group of animals per cage and administered by means of oral gavage, whereas 
the untreated groups (C/ART- and HCD/ART-) received the same volume of water, relevant 
to their body weights, by oral gavage. 
 
5.4. Tissue Collection and Processing 
 
Animals were systematically euthanized (two animals per day for four consecutive days, the 
first at 10:00 and the second at 13:00, until 40 animals were harvested) by intraperitoneal 
injection of 160 mg/kg sodium pentobarbitone (Bayer (Pty) Ltd. Isando, Gauteng, RSA) after 
which the hearts were immediately removed by the Medical physiology representative for 
further studies. After the heart removal, the liver was removed and liver mass was taken. 
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Followed by the removal of the distal thoracic aorta with surrounding perivascular adipose 
tissue (PVAT), splenic region of the pancreas, and right kidney. All organ samples were 
immediately fixed in 4% paraformaldehyde (PFA) after removal for histological processing. 
The time lapse between the opening of the thoracic cage and harvesting of the organs for the 
present study was kept to a minimum as far as practically possible. All tissue samples were 
stored at 4 °C for 24 hours, after which the samples were transferred to labelled cassettes 
(Figure 5.2), followed by standard histological tissue wax processing procedures (Appendix 
D).  
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 18 
 
 
Figure 5.2 Pancreas, liver and kidney tissue cut and positioned for embedding cassettes. 
A) Pancreas splenic region cut and B) placed in embedding cassette. C) Left liver lobe cut 
triangular and D) placed on side in embedding cassette. E) Right kidney cut cross-
sectional and F) placed cross-sectional in embedding cassette.  
 
After processing, all samples were embedded in metal cassettes, using a Leica EG 1160 
embedder, in pre-heated paraffin wax (60 °C). The pancreatic tissue was placed into the 
cassette, whereas the triangular liver section was placed on the side to show the hepatocytes 
and portal tracts of the liver. Cross-sections of the kidney and distal thoracic aorta with 
surrounding PVAT were placed perpendicular to the cassette, allowing cross-sections of the 
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glomeruli, arcuate arteries, and the aorta. Tissue blocks obtained were placed on an ice table 
for approximately two hours before sectioning.  
 
5.5. Pancreas methodology 
 
Two sections of pancreatic tissue were cut using a Leica RM 2125 RT microtome (Appendix 
E). The first section was cut at 3 μm for immunohistochemistry (IHC), floated in a warm 
waterbath placed on positively charged microscopic slides and used for morphometric analysis. 
The second section was cut at 5 μm for haematoxylin and eosin (H&E), placed on frosted 
microscopic slides and used for pathology assessment.  
 
5.5.1. Immunohistochemistry (IHC)  
 
All pancreatic sections on positively charged slides underwent double-labelling for insulin and 
glucagon of the pancreatic islets (Figure 5.3). A standard operating procedure at the 
Biomedical Research and Innovation Platform at the South African Medical Research Council 
(SOP ICC\B7-V01, Appendix G) for double labelling paraffin sections was used. A polyclonal 
rabbit anti-glucagon (Dako, North America) which labelled the alpha (α) cells, and monoclonal 
guinea pig anti-insulin (Dako, North America) which labelled the beta (β) cells was used. After 
dewaxing the pancreatic tissue sections with xylene and alcohol, sections were blocked for 
endogenous peroxidase followed by 0.05M Tris buffered saline (TBS) pH 7.2 and 0.1 M 
Phosphate buffered saline (PBS) pH 7.2. Normal goat serum (NGS, 1:20 dilution) was then 
added to the slides in a moisture chamber for 20 minutes, to block non-specific binding. Anti-
glucagon (100 μl) diluted at 1:100 was added to the sections in the moisture chamber and 
incubated for 30 minutes where after biotinylated anti-rabbit IgG (1:200 dilution) was added 
onto the sections in the moisture chamber for 30 minutes to remove cross-reactivity that could 
interfere with the specific binding, followed by Vectastain® (ABC kit, North America) for one 
hour, to detect biotinylated molecules. Liquid 3’3-diaminobenzidine (DAB) plus chromogen 
solution (K3468, Dako, North America) was then added to the sections on a rack over the sink 
for five minutes. Sections where then placed back into the moisture chamber and normal horse 
serum (NHS, 1:20 dilution) was added for 20 minutes, for blocking non-specific binding. This 
was followed by adding the anti-insulin (100 μl) diluted at 1:10 000 to the sections in the 
moisture chamber and incubated overnight (20-24 hours) at 4 °C. The following day, slides 
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were allowed to reach room temperature, followed by the addition of Envision™ kit and a 
Mayer’s haematoxylin counterstain for two to four minutes.  
 
 
 
Figure 5.3 A double IHC labelling technique used on pancreatic islets, labelling insulin 
(β-cells in pink) and glucagon (α-cells in brown). 100x magnification, scale bar = 50μm 
 
5.5.2. Haematoxylin and eosin (H&E) 
 
A haematoxylin and eosin (H&E) stain was performed on all pancreatic sections on the frosted 
slides using a Leica Auto Stainer XL (SOP, Appendix F) with a pre-programmed protocol. 
 
5.5.3. Morphometric analysis 
 
Pancreatic sections were scanned using the Nikon Eclipse Ti-S with PRIOR ProScan III and 
Nikon automated tissue scanning software (NIS Elements AR4.40) (Appendix I) at a 100 x 
magnification (10 x objective lens). Images were captured with a 10% overlap and were then 
stitched together forming a composite image of the section. Morphometric analysis was 
conducted at the South African Medical Research Council (SAMRC) with the use of Leica 
QWin V3 software (Germany). The total section area was highlighted and the area measured 
in square micrometres (μm²) per section, this included the pink beta cell, brown alpha cell and 
blue haematoxylin stained areas. Thereafter, each pancreatic islet is highlighted (Figure 5.4.A) 
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to measure the total islet area in square micrometres (μm²). A circumference was traced around 
the islet to ensure that other possible brown and pink stains outside of the islet would be 
excluded (Figure 5.4.B). The brown alpha (glucagon) cell area was highlighted and measured 
in square micrometres (μm²) to obtain an average alpha cell area per section (Figure 5.4.C). 
The pink beta (insulin) cell area was then highlighted and measured in square micrometres 
(μm²), obtaining an average beta cell area per section (Figure 5.4.D). This was done for all 
islets per section area and the number of islets per section area was counted and measured in 
square millimetre (mm²). A total of 1380 islets were measured to obtain significant results, 
resulting in an average of 300 islets per group (N=10 animals/group) (Table 18, Appendix K). 
 
 
Figure 5.4 Analysis of double labelled IHC pancreatic islets. A) The entire islet is 
highlighted in red to obtain total islet area, B) a green circumference is traced around the 
perimeter of the islet, measuring the islet area. C) Brown stained areas are highlighted in 
blue, measuring alpha cell area and D) pink stained areas are highlighted in green, 
measuring beta cell area. 100x magnification, scale bar = 50 μm. 
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5.5.4. Pathology assessment 
 
The H&E stained sections were assessed for pathology by two histopathologists, a histologist 
and the researcher. Sections presented with pathology were graded as follows; absent (0), mild 
(I), moderate (II), severe (III) and expressed as a percentage (%) of the total animal sample 
(N=40). The grading criteria are defined in Appendix J. 
 
5.6. Leptin intensity staining methodology 
 
The aorta with surrounding PVAT was sectioned at 5 μm and placed on positively charged 
slides for immunohistochemistry (IHC) analysis. The aortic PVAT adipocytes were classified 
according to their histological characteristics. White (unilocular) adipocytes were defined by 
one large lipid droplet (leaving a corresponding space in wax sections) and a thin cytoplasmic 
rim. Brown (multilocular) adipocytes were characterised by multiple small lipid droplets (Cinti 
1999; Cousin et al. 1992). Adipocytes with a single large lipid droplet surrounded by small 
droplets were defined as differentiating adipocytes (Cinti 1999).  
 
For IHC, affinity purified polyclonal anti-leptin antibodies (Abcam, ab117751, used for 
automated and non-automated systems) raised in rabbit were used to label the leptin protein 
expression within the aortic PVAT adipocytes. A standard *F protocol, used by LEICA 
Bondmax™ (Appendix H), with heat-mediated antigen retrieval using citrate based buffer 
pH6 (ER1 for 30 minutes) was employed on the Leica Bondmax™ using the Bond Polymer 
Refine detection kit (DS 9800). The hydrogen peroxide step was modified to 10 minutes to 
effectively quench endogenous peroxidase in red blood cells. Kidney glomeruli were used as a 
negative tissue control, whereas placenta samples were used as a positive tissue control to 
confirm the antigen targeted the relevant tissue cells (Figure 5.5). Controls underwent positive 
and negative reagent reaction, to ensure correct labelling and minimising background staining. 
 
Anti-leptin stained aortic PVAT sections were viewed using the Zeiss Axioskop2 light 
microscope. Photos were taken of two complete PVAT lobules on 25x magnification (2.5x 
objective X 10x magnification lens). In order to randomize the analysis, the following 
procedure was followed in all animals; a grid with set patterns (293.45μm x 293.45μm) was 
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placed on the 25x magnification photo of each lobule. Four set patterns were applied according 
to the placement of the tissue in the photograph (25x magnification). In each pattern five blocks 
were selected with the use of random numbers. These selected blocks were photographed at 
400x magnification, therefore 10 images per slide (5 blocks x 2 lobules) using the AxioVisio 
software (version 4.7.2.0., Germany). In the case where no unilocular adipocytes were seen in 
the 10 images, another set of five images per lobule were captured only where the unilocular 
adipocytes were seen. Leptin expression in unilocular adipocytes and differentiating adipocytes 
were classified by one researcher, who was blinded to the treatment groups, into four levels of 
staining intensity similar to methods used in Cinti et al. (1997). Classification levels were as 
follows; leptin negative (0), weak leptin positive (I), leptin positive (II), and intensely leptin 
positive (III) (Figure 5.5). The mode (value appearing the most) intensity level of each 
experimental group was determined.  
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Figure 5.5 Examples of the levels of leptin expression intensity, white adipocytes (A-D) 
and differentiating adipocytes (E-H). A & E) level 0, leptin negative. B & F) Level I, weak 
leptin positive. C & G) Level II, leptin positive. D & H) Level III, intense leptin positive, 
I & J) Negative (kidney glomeruli) and positive (placenta) controls. 
 
5.7.  Kidney methodology 
 
Each kidney section was trimmed by 20μm (4 x 5 μm), the first section of the kidney (25μm) 
was then placed on a frosted microscope slide and stained with H&E for morphometric analysis 
and pathology assessment. Haematoxylin and eosin (H&E) stain was performed on all kidney 
sections on frosted slides using a Leica Auto Stainer XL (SOP, Appendix F) with a pre-
programmed protocol. 
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5.7.1. Morphometric analysis 
 
Kidney sections were scanned using the Nikon Eclipse Ti-S with PRIOR ProScan III and Nikon 
automated tissue scanning software (NIS Elements AR4.40) at a 400 x magnification (40 x 
objective lens). Images were captured with a 10% overlap and stitched together forming a 
composite image of the kidney section. Thirty renal corpuscles were analysed per animal. To 
randomise the analysed renal corpuscles, the scanned kidney was divided into three parts: 
superior, middle and inferior. In each part, 10 renal corpuscles were measured, to randomise 
the 10 analysed renal corpuscles every fifth renal corpuscle was selected, thus 30 renal 
corpuscles per animal (1200 renal corpuscles in total). Similar to techniques used in Sedeek et 
al. (2013), renal corpuscle- and glomeruli –area (μm²), -diameter (μm), and –perimeter (μm) 
were measured and analysed (Figure 5.6). Diameter of the glomeruli were measured as 
follows; two lines (one horizontal and the other vertical) were placed perpendicular over the 
glomerulus, obtaining two sets of diameter values (one horizontally and the other vertically). 
An average of the two perpendicular lines were calculated and used as the diameter value for 
that specific glomeruli. This was done for each glomeruli measured per animal per group. 
  
Figure 5.6 Glomerulus with renal corpuscles traced in blue and glomerulus traced in 
green. The area, diameter and perimeter measurements of the corpuscle and glomerulus 
are calculated for each of the 1200 renal corpuscles. 400x magnification. Scale bar = 50μm 
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Additionally, the kidney arcuate artery tunica media and tunica adventitia thickness and lumen 
diameter were measured. Measurements of the tunica intima layer was excluded, due to the 
fact that it was very thin and difficult to measure. The exclusion criteria included arcuate 
arteries that were slightly or completely longitudinally cut. All arcuate arteries that appeared 
to be cross-sectioned were measured. The artery wall was measured at four points and the 
lumen at two lines, to eliminate as much variability as possible, obtaining an average for the 
wall thickness and an average lumen diameter. Two radial lines perpendicular to each other 
were placed over the image of the artery, thus crossing the artery wall at four points. Artery 
wall thickness was measured on these four points (Figure 5.7, green and red, 1-4), where an 
average of the four measurements were calculated to provide the arcuate artery wall thickness. 
The lumen diameter was measured on these two perpendicular lines, thus obtaining an average 
lumen diameter for the specific artery (Figure 5.7, blue, A-B).  
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Figure 5.7 Arcuate artery (purple) measurements; tunica media wall thickness (Green), 
tunica adventitia (red) and two lumen diameters (blue). 
 
5.7.2. Pathology assessment  
 
The H&E stained sections were assessed for pathology in conjunction with two 
histopathologists, a histologist and the researcher. Pathology on each section was classified 
with absent (0) and present (1). The sections presented with pathology were graded as follows; 
mild (I), moderate (II), severe (III) and expressed as a percentage (%) of the total sample size 
(N=40). The grading criteria are defined in Appendix J. 
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5.8. Liver methodology 
 
Liver sections were cut at 5 μm using a Leica RM 2125 RT microtome. The sections were 
placed on frosted microscopic slides to stain for H&E and used for pathology assessment.  
A haematoxylin and eosin (H&E) stain was performed on all liver sections on frosted slides 
using a Leica Auto Stainer XL with a pre-Programmed protocol. 
 
5.8.1. Pathology assessment 
 
The H&E stained sections were assessed for pathology in conjunction with two 
histopathologists, a histologist and the researcher. Pathology on each section was classified 
with absent (0) and present (1). The sections presented with pathology were graded as follows; 
mild (I), moderate (II), severe (III). Possible fatty changes were graded as follows; 0-25% (I), 
25-50% (II), 50-75% (III), and 75-100% (III). Data was expressed as a percentage (%) of the 
total sample size (N=40). The grading criteria are defined in Appendix J. 
 
5.9. Statistical Analysis 
 
Data are presented as mean ± standard error (SEM). Statistical analysis of the morphometric 
data was performed using the Variance Estimation, Precision and Comparison (VEPAC) 
descriptive statistics followed by (LSD) post hoc test from the Statistica® software (version 
12, StatSoft, Southern Africa—Research (Pty.) Ltd.). Statistical analysis of the pathology data 
was performed using a 2-way summary table with a Chi-square test from the Statistica® 
software (version 12, StatSoft, Southern Africa—Research (Pty.) Ltd.). Statistical significance 
was set at a p-value of less than 0.05 (p<0.05). 
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6. RESULTS 
 
6.1. Body mass 
 
The average initial body mass (grams, g) was in the same range for all four groups. An increase 
in body mass was seen in all four groups, however no group had more than 50% average body 
mass increase (Table 1). The HCD/ART+ group had a significant increase (p<0.022) in body 
mass compared to the C/ART- at termination (Table 1 and Figure 6.1). The C/ART+ and 
HCD/ART- groups had a higher body mass compared to the C/ART- group, however the 
increase was not significant (Figure 6.1). 
Table 1 Average body mass expressed in grams (g) and percentage (%) increase in each 
group.  
Group Initial body mass Body mass at termination % increase 
C/ART- 223.2 376,8 39.7ᵃ 
C/ART+ 224.2 399,6 43.1ᵃ ᵇ 
HCD/ART- 225.3 409,2 44.4ᵃ ᵇ 
HCD/ART+ 222.4 442,9 49.4ᵇ 
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Figure 6.1 Average percentage (%) increase in body mass in each group. A significant 
increase in the high-calorie diet ART group were seen compared to the lean control. 
 
6.2. Pancreas 
 
With the use of immunohistochemistry, total pancreatic islet area (μm²), alpha (α) and beta 
(β) cells area (μm²) were measured and analysed. In addition, the number of pancreatic islets 
per square millimetre (mm²) were analysed, Table 18 (Appendix K) indicates the number of 
islets measured per animal.  
 
6.2.1. Alpha and beta cell analysis 
 
Total pancreatic islet area (μm²) had no significant (p>0.678) changes between the four groups 
(Table 19, Appendix K). A trend, based on the mean values indicated that the total pancreatic 
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islet area in the C/ART+ group had a smaller total area size compared to the control (C/ART-) 
and HCD groups (HCD/ART- and HCD/ART+) (Table 2).  
 
Alpha (α) and beta (β) cell areas were not significantly changed between the four groups 
(Figure 6.2, Table 20, Appendix K). However, a trend based on the mean values indicated 
that the average α-cell area in the HCD/ART- group was marginally larger in size compared to 
the other three groups (Figure 6.2). The average β-cell area in the C/ART+, HCD/ART- and 
HCD/ART+ groups was less compared to the control (C/ART-) group, with the C/ART+ group 
having the smallest β-cell area compared to the control (C/ART-) group (Figure 6.2). 
 
Table 2 Average area of alpha (α)-, beta (β)-cells and total islet area from the pancreatic 
islets expressed as surface area (μm²) ± SEM. 
Average area (μm²±Std.Err.) of islets and cells within pancreatic islets 
  Alpha (α) cells Beta (β) cells Total Islet area 
C/ART- 657,99 ± 282,02 3031,3 ± 282,02 4230,55 ± 1053,42 
C/ART+ 693,37 ± 265,57 2421,52 ± 265,57 3831,39 ± 992,42 
HCD/ART- 1014,34 ± 263,62 2981,13 ± 263,62 4752,12 ± 985,57 
HCD/ART+ 638,39 ± 237,41 2655,71 ± 237,41 4204,47 ± 885,91 
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Figure 6.2 Alpha (A)-cell (blue line) and beta (B)-cell (red line) area (μm²) sizes of the 
pancreatic islets in the four groups. Alpha cells secrete glucagon and beta cells secrete 
insulin. Alpha- and beta-cell areas showed no statistically significant differences between 
the four groups. 
 
6.2.2.  Pancreatic islet number per square millimetre (mm²)  
 
The number of pancreatic islets per pancreas mm² had no significant difference (p>0.13) 
between the four groups (Table 21, Appendix K). A trend based on the mean values indicated 
that both the HCD/ART- and HCD/ART+ groups had more islets per pancreas section area 
than the C/ART- group (Figure 6.3).  
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Figure 6.3Average number of pancreatic islets per square millimetre (mm²). No 
statistically significant increase in number of pancreatic islets per section area were seen 
between the four groups. 
 
6.2.3. Pathology 
 
Haematoxylin and eosin stain was used to assess pathology each pancreas section. Pathology 
was graded accordingly; absent (0), mild (I), moderate (II), severe (III), and expressed in 
percentages (%). No pathology changes were found in the pancreas between the four groups. 
 
6.2.4. Additional findings 
 
When analysing the pancreas sections for pathology changes, additional findings were seen. 
Eosinophilic proteinaceous casts in collecting ducts were found in 2/40 of the pancreas samples 
(Figure 6.4). One was found in the C/ART+ group, whereas the other one was found in the 
HCD/ART- group. The HCD/ART+ group had two (5%) reactive lymph nodes (sectioned by 
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chance) (Table 22, Appendix K). These findings are not important for the current study, but 
are interesting to note. 
 
 
Figure 6.4 Pancreatic tissue with A) no pathology and B) a mildly dilated collecting duct 
containing eosinophilic proteinaceous material (indicated by the arrow). 200x 
magnification. Scale bar = 100μm 
 
6.3. Kidney 
 
With the use of haematoxylin and eosin stained kidney sections, the corpuscle, glomeruli, renal 
space, and arcuate arteries was measured and analysed.  
 
6.3.1. Corpuscle and glomeruli analysis 
 
The corpuscle area (p>0.392), corpuscle diameter (p>0.377) and corpuscle perimeter (p>0.351) 
showed no significant differences between the four groups (Appendix L), all results to follow 
relates to a trend seen based on the mean values. The glomeruli area (p>0.371), glomeruli 
diameter (p>0.357) and glomeruli perimeter (p>0.494) showed no significant differences 
between the four groups (Appendix L). No significant differences in renal space area 
(p>0.437) were seen between the four groups (Appendix L). 
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Table 3 Corpuscle - and glomeruli -area (μm²), -diameter (μm), -perimeter (μm) and renal space (μm²) between the four groups. Area is 
expressed as square micrometres (μm²) ± SEM. Corpuscle- and glomeruli -diameter and -perimeter are expressed as micrometres (μm) ± 
SEM. 
 Groups 
 C/ART- C/ART+ HCD/ART- HCD/ART+ 
Glomerulus     
Area (μm²) 114436,94 ± 46206,22 121156,44 ± 46206,22 213390,12 ± 46206,22 117263,63 ± 46206,22 
Diameter (μm) 372,33 ± 38,69 384,87 ± 38,69 459,22 ± 38,69 377,7 ± 38,69 
Perimeter (μm) 1571,53 ± 186,52 1622,71 ± 186,52 1935,01 ± 186,52 1609,73 ± 186,52 
     
Corpuscle     
Area (μm²) 161402,31 ± 72033,55 162217,97 ± 72033,55 307367,41 ± 72033,55 160724,65 ± 72033,55 
Diameter (μm) 441,28 ± 49,21 445,85 ± 49,21 544,65 ± 49,21 442,7 ± 49,21 
Perimeter (μm) 1536,85 ± 168,15 1557,45 ± 168,15 1901,69 ± 168,15 1541,81 ± 168,15 
     
Renal Space 46965,37 ± 26150,0 41061,52 ± 26150,0 93977,29 ± 26150,0 43461,02 ± 26150,0 
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The corpuscle- and glomeruli -area, -diameter and -perimeter in the HCD/ART- group were 
larger compared to the other three groups, however the changes were not significant. The 
corpuscle- and glomeruli -area, -diameter and -perimeter between the C/ART-, C/ART+ and 
HCD/ART+ had similar sizes (Table 3). The renal space area in the HCD/ART- group was 
larger than the other three groups, however the changes were not significant. The renal space 
area between the C/ART-, C/ART+ and HCD/ART+ had similar areas (Table 3). 
 
6.3.2. Arcuate artery analysis 
 
The total lumen diameter (p>0.417), total tunica media thickness (p>0.850) and total tunica 
adventitia thickness (p>0.735) showed no significant differences between the four groups 
(Appendix L), all results to follow relates to a trend seen based on the mean values. The lumen 
diameter in the ART groups (C/ART+ and HCD/ART+) was marginally increased compared 
to the control (C/ART-) and the HCD/ART- groups (Table 4). The tunica media and adventitia 
layer thickness were increased in the ART groups (C/ART+ and HCD/ART+) compared to the 
control (C/ART-) and the HCD/ART- groups (Table 4).  
 
Table 4 Lumen diameter, tunica media and tunica adventitia layer thickness of the 
arcuate arteries in the kidney between the four treatment groups. Diameter and thickness 
are expressed as micrometres (μm) ± SEM. 
Arcuate artery lumen and layer thickness μm ± SEM 
Groups Lumen Tunica Media Tunica Adventitia 
C/ART- 460,87 ± 39,43 125,94 ± 15,25 138,96 ± 16,44 
C/ART+ 584,2 ± 53,27 174,9 ± 14,21 181,48 ± 16,86 
HCD/ART- 474,01 ± 38,10 135,51 ± 23,47 138,18 ± 11,76  
HCD/ART+ 666,53 ± 72,73 179,98 ± 18,38 175,81 ± 20,42 
 
6.3.3. Pathology 
 
Pathology in haematoxylin and eosin stained each kidney section was graded accordingly; mild 
(I), moderate (II), severe (III), and expressed in percentages (%) of the total sample size (N=40) 
(Table 23, Appendix L).  
 
Vacuolisation of proximal convoluted tubules were seen in all four groups, however no 
significant differences were seen between the four groups (p>0.385). Vacuolisation in all four 
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groups had mild to moderate grading, with mild vacuolisation seen in the majority of the 
samples (Table 5). Mild swelling of the proximal convoluted tubules were seen in the 
HCD/ART- (40%) and HCD/ART+ (10%) groups, indicating significant (p<0.017) proximal 
convoluted tubule swelling differences between the groups (Table 5).  
 
Table 5 Kidney vacuolisation and swelling of proximal convoluted tubules and basophilic 
material pathology expressed in percentages (%) of each group groups.  
Kidney Pathology 
  C/ART- C/ART+ HCD/ART- HCD/ART+ 
Vacuolisation     
Absent 30% 20% 10% 50% 
Mild 60% 70% 80% 30% 
Moderate 10% 10% 10% 20% 
Swelling     
Absent 100% 100% 60% 90% 
Mild 0% 0% 40% 10% 
 
6.3.4. Additional findings 
 
When analysing the kidney sections for pathology, additional findings were seen, although 
these findings are not important for the current study, but are interesting to note. Basophilic 
material in tubular lumens were seen in 8/40 (20%) of kidney samples, which are found in 
normal functioning renal tubules (Figure 6.5). Three out of the eight samples were found in 
the C/ART- group, and another three were found in the HCD/ART- and one found in the 
C/ART+ and HCD/ART+ groups. One sample in the HCD/ART- group had a focus of 
neutrophilic infiltration. 
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Figure 6.5 Kidney tissue indicating A) no pathology, B) mild vacuolisation (arrows) of the 
cytoplasm in the proximal convoluted tubular epithelial cells, C) swollen proximal 
convoluted tubules, and D) basophilic material (arrow) in the lumen of the proximal 
convoluted tubules. 200x magnification. Scale bar = 50μm 
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6.4. Liver 
 
Haematoxylin and eosin stain was used to analyse pathology in the liver sections. Pathology 
present in each section was graded accordingly; absent (0), mild (I), moderate (II), severe 
(III), and expressed in percentages (%) of the total sample (N=40). Fatty change was graded 
as follows; 0-25% (I), 25-50% (II), 50-75% (III), 75-100% (IV) (Appendix M). 
Mild to moderate granular appearances were seen in all four groups, however no significant 
(p>0.445) granular appearances were seen between the groups (Figure 6.6). The C/ART- group 
had 90% granular appearance, whereas the other three groups had granular appearances ranging 
from 50% - 80% (Table 6).  
Vacuolisation of hepatocytes were seen in all four groups, significant vacuolisation (p>0.5) 
was observed between the four groups, however 44% vacuolisation was seen in the lean control 
(C/ART-) group (Figure 6.6). The HCD (HCD/ART- & HCD/ART+) group had 40% and 30% 
mild vacuolisation, respectively (Table7). Fatty change was seen in all four groups, with 20% 
(2/10) mild (0-25%) fatty change in the C/ART- and C/ART+ groups. The HCD (HCD/ART- 
& HCD/ART+) groups each had 10% (1/10) mild (0-25%) fatty change (Table 6). 
 
Table 6 Liver hepatocyte vacuolisation and granular appearance in the cytoplasm 
pathology expressed in percentages (%) between groups. 
Liver Pathology 
  C/ART- C/ART+ HCD/ART- HCD/ART+ 
Granular appearance     
Absent  10% 50% 20% 30% 
Mild 
60% 40% 70% 60% 
Moderate 30% 10% 10% 10% 
Vacuolisation     
Absent  56% 100% 60% 70% 
Mild 44% 0% 40% 30% 
Fatty Change (micro- and 
macrovesicular)     
Absent 80% 80% 90% 90% 
Mild (0-25%) 20% 20% 10% 10% 
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Figure 6.6 Liver tissue indicating A) no pathology, B) mild granularity (arrows) of the 
cytoplasm of hepatocytes, and C) moderate vacuolisation (circles) and granular 
appearance (arrows). 200x magnification. Scale bar = 100μm 
 
6.5. Aortic PVAT leptin intensity 
 
Both unilocular and differentiating adipocytes in group C/ART- were classified as level II, 
showing a leptin positive cytoplasmic rim (Figure 5.5C & G). Both unilocular adipocytes and 
differentiating adipocytes were classified as level III in the C/ART+ group showing an intense 
leptin positive cytoplasmic rim (Figure 5.5D & H). Unilocular adipocytes in the HCD/ART- 
group had a level II classification, indicating a leptin positive cytoplasmic rim (Figure 5.5C). 
The differentiating adipocytes had a level I classification, showing a weak leptin positive 
cytoplasmic rim (Figure 5.5F). In the HCD/ART+ group the unilocular adipocytes had a 
classification of level I, showing a weak leptin positive cytoplasmic rim (Figure 5.5B). The 
differentiating adipocytes in this group was classified as level 0, indicative of leptin negative 
staining (Figure 5.5E).  
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Table 7 Leptin staining intensity of differentiating and unilocular adipocytes in the 
aortic PVAT between groups. 
 
Aortic PVAT adipocyte Leptin intensity level 
Groups Differentiating adipocytes Unilocular adipocytes 
C/ART- II II 
C/ART+ III III 
HF/ART- I II 
HF/ART+ 0 I 
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7. DISCUSSION 
 
Both obesity and antiretroviral treatment (ART) have been associated with diseases such as 
hypertension, lipodystrophy, metabolic syndrome and type 2 diabetes (Sutinen & Yki-Järvinen 
2007; Shah, Alio, et al. 2012). Antiretroviral treatment has been associated with lipodystrophy, 
either in the form of fat loss, known as lipoatrophy, or by fat accumulation, known as 
lipohypertrophy (Parakh et al. 2009). A study by Ogunmola et al. (2014) indicated that the 
body mass index (BMI) and obesity had no significant changes between HIV-positive 
individuals receiving no antiretroviral treatment and HIV-positive individuals receiving ART. 
The diet used to induce obesity in the present study was a high-calorie diet, which is commonly 
a risk factor for type 2 diabetes (Everitt et al. 2006). The present study showed no significant 
increase in body mass in the high-calorie diet (HCD/ART-) group compared to the lean control 
(C/ART-) group, suggested that a 16 week high-calorie diet on its own had no significant effect 
on body mass. However, a significant increase (10%) in the high-calorie diet drug treated group 
(HCD/ART+) compared to the lean control group suggested that oxidative stress played a role 
in the increase of body weight in this group. Obesity caused by oxidative stress stimulates white 
adipose tissue changes, causing adipocyte differentiation and increased size, whereas obesity 
inducing oxidative stress has contributing factors, such as chronic inflammation, tissue 
dysfunction and hyperleptinemia (increased circulating leptin hormone) (Savini et al. 2013).  
A study on body mass and the leptin hormone in HIV-infected patients by Nagy et al. (2003) 
reported that individuals showing signs of lipohypertrophy had high circulating leptin levels 
(hyperleptinemia), whereas individuals with signs of lipoatrophy had lower leptin levels 
(hypoleptinemia). 
 
Perivascular adipose tissue (PVAT) is metabolically active by secreting various 
adipocytokines, such as leptin which is important in regulating appetite (Szasz et al. 2013; 
Mandal 2014). Antiretroviral treatment causes adipose tissue changes, which in turn may cause 
leptin expression alterations (Jan et al. 2004; Lagathu et al. 2004). Perivascular adipose tissue 
in lean animals contributes to the regulation of vascular homeostasis; however, in obesity, 
PVAT secretes increased amounts of pro-inflammatory adipocytokines such as leptin 
accompanied by decreased expression of anti-inflammatory adipocytokines, such as 
adiponectin (Lehman et al. 2010; Raucci et al. 2013).  
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Increased calorie intake causes adipose tissue mass to increase which alters adipocytokine 
secretion from adipocytes in adipose tissue (Halberg et al. 2009; Weisberg et al. 2003). 
Increased leptin levels have been associated with elevated blood pressure suggesting that leptin 
play a role in obesity-related hypertension (Bravo et al. 2006; Martin et al. 2008). Previous 
studies have suggested that the leptin (ob) gene is only expressed in mature white adipocytes 
(Masuzaki et al. 1995), whereas other researchers have suggested that the leptin (ob) gene is 
expressed in both brown adipose tissue (BAT) and white adipose tissue (WAT) (Moinat et al. 
1995). Cinti et al. (1997) reported that leptin expression was detected in adipocytes at the 
multilocular stage of differentiation, suggesting that leptin is expressed by all lipid containing 
adipocytes within white adipose tissue depots. Therefore, the present study, using an 
immunohistochemical labelling technique, focused specifically on unilocular adipocytes found 
in the WAT clusters of the aortic PVAT and the differentiating adipocytes found near or within 
these WAT clusters. Results show that ART alone was associated with a more intense leptin 
expression in unilocular adipocytes compared to the other experimental groups, whereas the 
untreated groups (C/ART- and HCD/ART-) showed a more positive leptin expression 
compared to the weak leptin expression in the high-calorie diet combined with ART 
(HCD/ART+) group. The difference in leptin expression between the ART group and a high-
calorie diet combined with ART may be due to leptin deficiency in the adipocytes in the latter 
as leptin deficiency can be caused by either a lack of leptin secreting adipocytes (Oral & Simha 
2002) or by the mutation of the leptin (ob) gene, which is seen in severe obesity (Farooqi et al. 
2002). Additional results on the size of the adipocytes in the aortic PVAT indicated that the 
HCD/ART- and HCD/ART+ groups had smaller unilocular adipocytes compared to the lean 
control group, suggesting that the weak to no leptin intensity may possibly be due to the lack 
of leptin secreting adipocytes. Further analysis on the number of adipocytes and leptin gene 
expression in the aortic PVAT would provide sufficient results on the effect of this cART (FTC, 
TDF and EFV) and HCD used in the present study. 
 
The differentiating adipocytes in the C/ART+ group were seen to have a more intense leptin 
expression compared to the other three experimental groups. These observations suggests that 
ART on its own may cause hyperleptinemia (Nagy et al. 2003), which in turn may lead to leptin 
resistance (Knight et al. 2010). Leptin resistance is associated with hyperinsulinemia, insulin 
resistance and diabetes, causing decreased insulin secretion in the pancreatic beta (β)-cells. 
Therefore, a link is established between obesity and diabetes (Martin et al. 2008).  
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Pancreatic islets maintain blood glucose homeostasis with the secretion of peptide hormones 
such as insulin from beta (β)-cells and glucagon from alpha (α)-cells (Matschinsky & Ellerman 
1967). A study on morpometric analysis of the pancreatic islets in obese mice by Slavin et al. 
(2010) showed that islet number and insulin secreteion increased with obesity. Pancreatic 
toxicity is a side effect of ART which may lead to pancreatitis (Neuman et al. 2012). In a study 
done on mice by Oliveira et al. (2014) the pancreatic islet morphology (characterised as round 
to oval shape, surrounded by a very thin capsule of reticular fibres) in mice on a high-fat diet 
showed no significant changes compared to the control mice fed a regular chow diet. Pancreatic 
islets in the present study had no irregular shaped islets, suggesting that the cART and the HCD 
used in the present study had no effect on the shape of pancreatic islets. The present study 
showed no significant differences in total pancreatic islet area between the lean control group 
and the ART and HCD groups, suggesting the cART and a high-calorie diet used in the study 
caused no significant increase in total pancreatic islet area. However, the high-fat diet group in 
the study by Oliveira et al. (2014) showed a significant increase in islet and β-cell mass, and 
increase in the number of islets per section. The diet used for the HCD groups in the present 
study had lower percentages fat, carbohydrates and protein values compared to the high-fat diet 
used by Oliveira et al. (2014). The different nutritional values of the HCD used in the present 
study could possibly be the cause for the lack in significant changes seen in islet area and 
number. Results by Slavin et al. (2010) on the morphological analysis of pancreatic islets in 
obese mice indicates that obese mice had increased numbers of islets and increased islet sizes 
compared to lean mice. A study by Barbosa et al. (2013) indicated that HIV infected patients 
receiving ART had increased number of islets compared to HIV infected patients that did not 
receive ART. Based on a trend in the present study, the total islet area and number of islets in 
the present study were increased in the high-calorie diet untreated group compared to the lean 
control group. This suggests that potentially a longer administration of the high-calorie diet 
and ART would lead to significant increases in islet size and number of islets, therefore have 
similar characteristics to obesity in rats seen in previous studies.  
 
With type-2 diabetes mellitus (T2DM), beta (β-) cells remain unchanged, however the cells fail 
to produce suffucient insulin to maintain normal blood glucose levels. A trend, based on the 
average values, indicated that insulin secreting β-cells in the ART and HCD groups (C/ART+, 
HCD/ART- & HCD/ART+) were smaller in area compared to the lean control (C/ART-) group. 
This suggested that longer exposure to ART in combination with a high-calorie diet could lead 
to decreased insulin secreting β-cells, leading to decreased insulin secretion which are 
Stellenbosch University  https://scholar.sun.ac.za
 45 
 
associated with T2DM, and is one of the metabloic disorders asssociated with obesity 
(Adeyemi et al. 2010). In addition to impaired β-cells production with T2DM, glucagon 
secreted from alpha (α-) cells are also disrupted, with and increase in glucagon secreting cells 
(Brereton et al. 2014). However, based on the average glucagon secreting α-cell area, the high-
calorie diet untreated group (HCD/ART-) and ART group (C/ART+) were larger in area 
compared to the lean control (C/ART-). The increase in glucagon secreting α-cells in the 
present study correlated with findings by Brereton et al. (2014), which indicated a decrease in 
insulin staining cells and an increase in glucagon staining cells with the onset of chronic 
hyperglycaemia which is associated with T2DM (Brereton et al. 2014). The increased glucagon 
secreting α-cells in the present study could have more significance with longer treatment and 
additional blood glucose measurments to confirm hyperglycaemia.  In the study by Slavin et 
al. (2010) a decrease in glucagon stained cells in obese mice were noted compared to the lean 
mice. The insulin stained cells in the same study were increased in the obese mice compared 
to the lean mice, suggesting β-cell hyperplasia, which could be due to pancreatic homeodomain 
protein PDX-1 or islet neogenesis associated protein or mitogenic growth factor (Slavin et al. 
2010).  
 
In the exocrine pancreas, pathological changes in HIV-infected patients before the use of ART 
included intense acinar or parenchymal atrophy and decreased zymogen granules (Barbosa et 
al., 2013). Whereas in the endocrine pancreas, alterations seen in HIV-infected patients 
receiving ART has led to hypotheses that the endocrine portion of the pancreas is affected by 
combination ART (cART) (Dragovic, 2013). In a study by Barbosa et al. (2013), the exocrine 
pancreas showed that decreased dysplasia like alterations, increased pancreatic atrophy, 
increased apoptosis and parenchymal steatosis maintenance were more evident in HAART 
group. Another study by Manfredi & Calza (2008) showed that nucleoside reverse transcriptase 
inhibitor (NRTI) drugs causes an increase in serum pancreatic enzymes, which leads to acute 
pancreatitis. In the present study no pathology was present in any of the groups studied, 
suggesting that the six week cART (of FTC, TDF and EFV) and a 16-week HCD caused no 
pathological changes. The lack of pathology in the ART and HCD groups could be due to the 
short-term of ART and high-calorie diet or the combination ART used in the study. Several 
human studies on indicate pancreatic toxicity in individuals diagnosed with HIV and receiving 
ART, therefore it could be suggested that the HIV combined with ART may possibly cause the 
severe pancreatic toxicity (Elfane et al. 2016; Dragovic 2013). 
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Long term exposure to ART is associated with significant renal toxicity which causes kidney 
injury (Jao & Wyatt 2016). A study done by Fabian et al. (2013) showed mild glomerular 
enlargement within seven months of ART in humans, while morbidly obese patients showed 
an increase in glomeruli size (Goumenos et al., 2009) . The renal corpuscle- and glomeruli -
area (μm²), -diameter (μm) and -perimeter (μm) in the present study had no significant 
differences between the lean control, ART and HCD groups. However, the ART (C/ART+) 
had smaller renal corpuscle- and glomeruli -area, -diameter and -perimeter compared to the 
lean control group, suggesting that the cART (of FTC, TDF and EFV) used in the present study 
will have decreased glomerular filtration rate, possibly due to the Tenofovir which effects the 
tubular function therefore causes decreased glomerular filtration rate (Post et al. 2010). The 
renal space area (μm²) also had no significant differences between the lean control, ART and 
HCD groups, however based on the average values the ART group was smaller compared to 
the lean control group, suggesting that the glomeruli shrunk. This suggested that a six week 
administration of the specific cART (of FTC, TDF and EFV) used in the present study had no 
significant histological effect on the renal corpuscle, the glomeruli and renal space. 
 
Antiretroviral therapy has been implicated in atherogenesis (adhesion of monocytes and 
lymphocytes to the endothelial cell surface) in blood vessels (Grinspoon & Carr 2005), which 
in turn leads to arterial stiffness, migration of vascular smooth muscle cells from the tunica 
media to the tunica intima and therefore increased blood pressure and hypertension (Eira et al. 
2012; Lo and Plutzky, 2012). Arteries undergo hypertrophic remodelling with hypertension, 
causing the arterial wall to thicken (Jacobsen & Holstein-Rathlou, 2010). In obese individuals, 
adipose tissue encapsulates the kidneys, which penetrates the medulla causing compression, 
increased arterial pressures and renal-pressure natriuresis, which could explain the relationship 
between abdominal obesity and hypertension (Hall 2003). Changes occurring in the kidney due 
to obesity may cause compensatory mechanisms which leads to increased glomerular wall 
tension and glomerular hypertrophy. These glomerular changes reduces the filtration surface 
area which leads to increased blood pressure (Hall et al. 2014). The present study showed no 
significant differences in the arcuate artery lumen diameter, tunica media thickness and tunica 
adventitia thickness. However, the ART groups (C/ART+ and HCD/ART+) showed larger 
lumen diameter, thicker tunica media and adventitia compared to the lean control and high-
calorie diet untreated group. Although not significant, the trend seen of increased tunica media 
Stellenbosch University  https://scholar.sun.ac.za
 47 
 
and adventitia suggests that the cART used in the study could initiate hypertrophic remodelling 
in the arcuate arteries. 
 
Nephrotoxicity has been seen with specific antiretroviral agents (Jao & Wyatt 2016). High 
doses of Tenofovir (TDF) had pathological effects such as renal failure and/or tubular 
dysfunction (Karras et al. 2003). Emtricitabine (FTC) caused no nephrotoxicity, whereas 
Efavirenz caused minimal acute renal failure (decline in renal filtration function) (Jao & Wyatt 
2016). In the present study mild to moderate vacuolisation of the proximal convoluted tubules 
were present in all four groups, with the highest percentage (90%) in the high-calorie diet 
untreated group. Swelling of the proximal convoluted tubules were only present in the HCD 
groups (HCD/ART- and HCD/ART+), with 40% swelling in the high-calorie diet untreated 
group. The vacuolisation and swelling of the proximal convoluted tubules lesions were very 
mild and interpretation was thus difficult, and could be due to possible fixation problems. 
However, lesions associated with vacuolisation and swelling may arise due to the variety of 
causes involving hypoxia or disruption of ATP production, mitochondrial injury, free radical 
formation, peroxidation, or perturbed cell signalling (Schiffer & Friederich-Persson 2017). 
These conditions mentioned associated with vacuolisation and swelling often affects the 
proximal convoluted tubules first (Schiffer & Friederich-Persson 2017). Vacuolisation may 
precede degeneration and necrosis and it is a very non-specific lesion that may also occur in 
normal animals (Padanilam 2003).  
 
The most common liver diseases with the onset of obesity and ART include; chronic hepatitis, 
liver steatosis and the development of liver cirrhosis (Yamauchi & Michitaka 1998; Neuman 
et al. 2012). In the present study, granular appearance in the hepatocytes of the liver were 
present in all groups, with the lean control group having the highest percentage (90%) of mild 
to moderate granular appearance. Mild to moderate granular appearance is indicative of active 
cytoplasmic organelles such as the mitochondria, smooth endoplasmic reticulum or 
peroxisomes. Granular appearance is not usually considered as a distinct pathological lesion, 
however together with other degenerative lesions such as vacuolar changes, it could indicate 
mild cell damage/induction (Lemasters & Nieminen 1997). Mild vacuolisation was present in 
the lean control and HCD (HCD/ART- and HCD/ART+) groups, these changes might be due 
to fluid or glycogen accumulation in the cytoplasm (Odze & Goldblum 2009). As granular 
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appearance and vacuolisation were mostly present in the lean control group (C/ART-), it 
indicated possible tissue fixation problems in the present study.  
 
The liver plays an important role in lipid metabolism, it is therefore possible that lipids may 
accumulate in the liver, specifically in hepatocytes, when there is an imbalance between the fat 
delivery into and out of the liver (Goodman 2016). In conditions such as metabolic imbalances, 
stress, and cellular injury; lipid droplets increase in size in the cytoplasm of the hepatocytes 
(Goodman 2016). Hepatic steatosis are signs of severe toxicity in long-term antiretroviral 
therapy (Brinkman et al. 1998). However, in the present study the hepatocytes had mild 
microvesicular (small intracytoplasmic fat vacuoles, accumulating in the cell) (0-25%) in all 
the groups, with 20% (2/10) in the lean control and ART groups and 10% (1/10) in the HCD 
(HCD/ART- and HCD/ART+) groups. Although Nucleoside reverse transcriptase inhibitors 
(NRTIs) is associated with hepatic steatosis (Grinspoon & Carr 2005), the NRTIs and NNRTIs 
used in the present study caused no severe hepatic steatosis. The microvesicular changes may 
possibly be hepatocellular vacuolar changes which may be of metabolic or toxic origin. The 
liver stores triglycerides and fatty acids in a response to feeding and fasting, where dietary fatty 
acids are absorbed from the small intestines. Therefore, the microvesicular accumulation in the 
two lean control animals may possibly be due to metabolic origins (Kawano & Cohen 2013). 
The ART interferes with the mitochondrial metabolism, which may cause accumulation of lipid 
droplets in the liver, because of the fatty acids that are being oxidized. Therefore, the 
observation of hepatic steatosis in patients receiving ARTs, can be a sign of early mitochondrial 
dysfunction (Cornejo-juárez et al. 2003). However, the mild microvesicular changes seen in 
the present study in all groups are still reversible and it is thus suggested that the six week 
cART and the 16-week high-calorie diet used in the study caused no severe macrovesicular 
changes or hepatic steatosis. 
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8. CONCLUSION 
 
The results in the present study had very little to no significant differences between the lean 
control, ART and HCD groups. Emtricitabine undergoes limited metabolism and is excreted 
by the kidneys, whereas Tenofovir is eliminated by the glomerular filtration and active tubular 
secretion. Both Emtricitabine (200mg) and Tenofovir (300mg) are eliminated at half-life (15.5 
and 17.6 hours, respectively) in healthy human individuals. When both of these drugs were co-
administered with other antiretroviral drugs such as Stavudine, Zidovudine, Abacavir, 
Adefovir Dipivoxil, Efavirenz, Indinavir, Lamivudine, Lopinavir/Ritonavir, no interactions 
between the drug were observed (Dando & Wagstaff 2004). This suggests that the specific 
cART used (FTC, TDF, and EFV) for six a week period caused no significant morphometric 
changes within the pancreas, kidney, liver, apart from the intense leptin stain in the ART 
positive group.  
 
The diet used for the HCD groups in the present study had lower percentages fat, carbohydrates 
and protein values compared to the high-fat diet used by Oliveira et al. (2014) and Murphy 
(2013). This difference in nutritional values could be a possible cause for the lack of significant 
changes seen in islet area and number. In the present study, the high-calorie diet alone and 
combined with the cART had only minor histological observational changes, although not 
significant compared to the lean control group. Further studies on the effects of this specific 
cART should be conducted with several administration periods, due to possible regeneration 
of the kidney on a longer period as seen by Fabian et al. (2013). These time periods in 
combination with a HCD could possibly lead to histomorphometric changes in various organs. 
As cART continue to develop, physicians treating HIV infected patients should remain aware 
of new and developing syndromes associated with the use of ART. 
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9. LIMITATIONS 
 
The harvesting time had a possible influence on the autolysis. Multiple researcher were 
collecting samples from the same animals, therefore waiting periods influenced the harvesting 
of tissue samples. Harvesting of the organs occurred as quickly as practically possible after the 
heart of the animal was removed. The organs were then immediately fixed in 4% PFA. 
Although the organs were harvested as quickly as possible, autolysis still occurred, as seen in 
some control animals showing pathology relating to autolysis.  Formaldehyde products such as 
4% PFA is effective in preserving tissue for histological examination (Hassel & Hand 1974).  
 
Fixation problems occurs when conditions were not optimal, which can permanently damage 
the tissue. The fixative used can influence the degree to which particles within the tissue will 
stain (Boenisch et al. 2001). With formaldehyde solutions, formic acid forms to produce an 
acidic solution. This acidic solution reacts with haemoglobin which produces an artefact 
pigment. With formaldehyde fixation the hydrophobicity is increased in the tissue, which leads 
to increased general background staining (Boenisch et al. 2001). Tissues that are prone to 
increased hydrophobicity include; connective tissue, squamous epithelium and adipocytes 
(Boenisch et al. 2001), this is a possible reason for the intense background staining in the PVAT 
tissue samples with the leptin antibody. Other reasons for background staining is due to the 
attachment of the primary antibody to highly charged groups in the connective tissue. Whereas 
non-specific positive staining is the cause of the primary antibody attaching to the connective 
tissue. This can be prevented with an innocuous protein solution (bovine serum albumin), 
which is applied before the primary antibody is applied. 
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APPENDICES 
 
 
Appendix A: Standard rat chow 
 Oval pellet, 10 mm x 25mm length 
 
Table 8: Nutritional Values of the Lean (Chow) Diet 
 Lean Diet (%) 
Fat 4.8 
Protein 17.1 
Carbohydrates 34.6 
Sucrose 5.2 
 
Appendix B: High-calorie diet 
 Normal rat chow (600g) was soaked in a 250ml warm water and dissolved sucrose mixture 
for 30 minutes 
 Dissolved sucrose consisted of 140g standard household sugar 
 The soaked mixture was crushed and melted vegetable fat (4 x 125g Holsum™) and eight 
cans of full cream sweetened condensed milk (8 x 385g Clover™) was added 
 The mixture was mixed and stored in a refrigerator 
 
Table 9: Nutritional Value of Holsum™ Vegetable fat 
 Per 100g 
Energy (KJ) 3700 
Protein (g) 0 
Glycaemic Carbohydrates (g) 
   Of which total sugar (g) 
0 
0 
Total fat (g) 
   Of which saturated fay (g) 
100 
67.8 
Trans fat (g) <1 
Monosaturated fat (g) 26.4 
Dietary fibre (g) 0 
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Total Sodium (g) 0 
Vitamin A (μg) 1380 
Vitamin D (μg) 15 
 
Table 10: Nutritional Value of Condensed Milk (Clover™) 
 Per 100g 
Energy (KJ) 1381 
Protein (g) 6.5 
Glycaemic Carbohydrates (g) 
   Of which total sugar (g) 
54 
54 
Total fat (g) 
   Of which saturated fay (g) 
8.7 
5.5 
Dietary fibre (g) 0 
Total Sodium (g) 127 
Calcium (mg) 284 
 
Table 11: Nutritional Value of the HCD 
 High-Calorie Diet (%) 
Fat 11.5 
Protein 8.3 
Carbohydrates 42 
Sucrose 20 
 
Appendix C: Antiretroviral treatment administration 
 Drugs administered was South Africa’s first line ARV FDC, Odimune (1100mg, Cipla 
MedPro (Pty) Ltd. Bellville, Western Cape, RSA) 
 The FDC contained 600mg Efavirenz (EFV), 200mg Emtricitabine (FTC) and 300mg 
Tenofovir Disoproxil Furmarate (TDF) 
 The FDC was initially suspended in jelly cubes, but the animals stopped eating the jelly 
cubes containing the FDC 
 The FDC purchased contained human recommended daily dosage of the active ingredients 
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 Tablets were grinded into a fine powder and the proper mass of powder for each group 
weekly were calculated and weighed according to the average total mass body (TMB) of 
each group 
 The dosage were adjusted weekly according to TMB changes  
 Daily FDC dosages were administered, starting with 3 ml water and later adjusted to 2 ml 
and finally to 1 ml 
 
Appendix D: Standard histological processing – materials and methods 
Materials  
 70%, 805, 95% and 99% Ethanol 
 Shandon Elliot Duplex Tissue processor 
 Embedding moulds 
 Paraffin wax (Paraplast, melting point 58°C 
 Xylene (Kimix, chemicals, Cape Town, South Africa) 
Methods: 
 Tissue samples were fixed in 5% PFA for 24 hours at 4°C 
 Tissue samples were then processed in the Duplex tissue processor following the 
procedure in Table 9 
 
Table 12: Tissue processing procedure 
Step Solution Time (minutes) Temperature (°C) 
1 70% Ethanol 30 40 
2 80% Ethanol 30 40 
3 95% Ethanol 45 40 
4 95% Ethanol 45 40 
5 100% Ethanol 45 40 
6 100% Ethanol 45 40 
7 100% Xylene 45 40 
8 100% Xylene 45 40 
9 Paraffin 30 58 
10 Paraffin 30 58 
11 Paraffin 30 58 
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12 Paraffin 30 58 
 
Appendix E: Standard histology materials 
 Acid alcohol (1%) 
 Alternate for Eosin-Phloxine B solution: Eosin Y solution 
 Ammonia (0.2%) 
 Bio-Scan Microscope Slides Frosted (Trifal Imaging, Chatsworth, USA) 
 Bio-Scan Microscope Slides Positive Charge (Trifal Imaging, Chatsworth, USA) 
 Bond Polymer Refine Detection kit (SMM Instruments (PTY) Ltd, Midrand, South Africa) 
 Bond™ Software ©Version 4.0 (Leica Biosystems, Melbourne, Australia) 
 Coplin staining jar 
 Cover Slide Box 
 Cover Slips  
 Distilled water 
 DPX Mountant (Kimix, chemicals, Cape Town, South Africa) 
 Duplex Tissue Processor  
 Embedding Cassette (SPL Life Sciences, Pocheon, Korea) 
 Eosin Yellowish (Kimix Chemicals, Cape Town, South Africa) 
 Eppendorf tubes (2.0ml) 
 Ethanol (99% & 96%) 
 Harris’s Haematoxylin 
 IKAMA® Magnetic Stirrer and Hotplate  
 Incubator (IH-150) 
 Leica Auto Stainer XL (Leica ST 5010, serial number 1732/07,2007) 
 Leica Bond Max immune-autostainer (SMM Instruments (PTY) Ltd, Midrand, South 
Africa) 
 Leica EG 1160 Embedder 
 Leica RM 2125RT microtome (SMM Instruments, Cat.) 
 M53C Drying Oven 
 Mayer’s Haematoxylin (Kimix Chemicals, Cape Town, South Africa)  
 Paraffin Wax (Paraplast, melting point 58°C) 
 Paraformaldehyde 
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 Pariodic Acid 
 Plastic rack 
 Schiff’s solution 
 Staining rack 
 Surgical blade, forceps 
 Tap water 
 Thermostat 
 Water Bath 
 Xylene (Kimix, chemicals, Cape Town, South Africa) 
 
Appendix F: Haematoxylin and Eosin (H&E) stain protocol 
 Slides were placed into a plastic rack in the autostainer. Slides were stained according to 
the pre-programmed procedure as tabulated in Table 10 
 
Table 13: H&E stain protocol procedure 
Step Solution Time Repetition 
1 Xylene 10 min 2 
2 Ethanol (99%) 5 min 2 
3 Ethanol (96%) 2 min 1 
4 Ethanol (70%) 2 min 1 
5 Distilled water 5 sec 1 
6 Haematoxylin 8 min 1 
7 Running water 5 min 1 
8 Ethanol (1% acid alcohol) 30 sec 1 
9 Running water 1 min 1 
10 Ammonia (0.2%) 45 sec 1 
11 Running water 5 min 2 
12 Ethanol (96%) 10 dips 1 
13 Eosin 45 sec 1 
14 Ethanol (96%) 5 min 2 
15 Xylene 5 min 2 
 
 Cover slides were mounted on completed slides with PDX. 
 Outcome: 
  Nuclei: Blue 
 Cytoplasm: Pink to red 
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Appendix G: Immunohistochemistry standard protocol – Pancreas 
List of referred SOPs used in the SOP for pancreas double staining: 
 ICC\B8-V01 Vectastain Kit 
 ICC\B14-V01 0.05M Tris Buffered Saline pH7.2 
 ICC\B9-V01 Biotinylated Mouse Anti-IgG 
 ICC\B16-V01 Normal Goat Serum 
 ICC\B17-V01 Normal Horse Serum 
 ICC\B18-V01 0.1M Phosphate Buffered Saline pH7.2 
 ICC\B20-V01 Polyclonal Anti-Glucagon 
 ICC\B17-V01 Monoclonal Anti-Insulin 
 ICC\B27-V01 Liquid DAB+ Substrate Chromagen System 
 ICC\B26-V01 Envision G/2 System/AP, Rabbit/Mouse Kit 
 
Table 14 Antibody information 
 
Antibody Source Clonality Raised Dilution Country 
Anti-Glucagon Dako Polyclonal Rabbit 1:100 
North 
America 
Anti-Insulin Dako Monoclonal 
Guinea 
pig 
1:10 000 
North 
America 
 
Materials: 
 Moisture Chamber 
 Staining Rack  
 Staining jar 
 1-10 l, 1-100 l, 20-200 l, 1000 l pipettes & tips 
 Magnetic Stirrer 
 Coverslips 
 Gloves 
 Magnetic stirrer 
 250ml measuring cylinder 
 Distilled Water 
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 Hydrogen Peroxide 
 0.05M Tris Buffered Saline (TBS) pH7.2 
 0.1M Phosphate Buffered Saline (PBS) pH7.2 
 Normal Goat Serum 
 Normal Horse Serum 
 Polyclonal Anti-Glucagon 
 Monoclonal Anti-Insulin 
 Biotinylated Rabbit Anti-IgG 
 Biotinylated Mouse Anti-IgG 
 Vectastain 
 EnvisionG/2 System/AP Kit 
 Liquid DAB+ Substrate Chromagen Solution 
 Haematoxylin 
 DPX Mounting Media 
 
Methods: 
• Dewax sections through xylene and alcohol. 
• Rinse slides in staining jar in distilled water. 
• Block for endogenous peroxidase with 3% hydrogen peroxide (H2O2) for five (5) minutes in 
staining jar. (6ml H2O2/194ml distilled water – left fridge). 
• Rinse slides with 0.05M TBS pH7.2 for five (5) minutes in staining jar.  
• Dry around section and add normal goat serum (NGS) 1:20 to slides in a moisture chamber 
  (Completely cover the section) for twenty (20) minutes at room temperature (18°C- 20°C). 
• Blot excess serum. (Do not rinse). 
• Add approximately 100µl anti-glucagon (P) (primary antibody) 1:100 to sections in moisture 
chamber and incubate at room temperature (18°C- 20°C) for thirty (30) minutes.  
• Jet wash with 0.05M TBS pH7.2 and rinse in staining jar in 0.05M TBS pH7.2 for five (5) 
minutes. (N.B. Make up Biotinylated Anti-Rabbit IgG and Vectastain)   
• Dry around sections and add Biotinylated Anti-Rabbit IgG 1:200 to slides in moisture 
chamber for (30) minutes at room temperature (18°C- 20°C). 
• Jet wash with 0.05M TBS pH7.2 and rinse in staining jar in 0.05M TBS pH7.2 for ten (10) 
minutes. 
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• Dry around sections and add Vectastain to slides in moisture chamber for one (1) hour at 
room temperature (18°C- 20°C). 
• Jet wash slides with 0.05M TBS pH 7.2 and rinse for ten (10) minutes in 0.05M TBS pH7.2 
in staining jar. 
• Dry around sections and add Liquid DAB+ Chromagen solution to slides on a rack over the 
sink for five (5) minutes. (Check progress under microscope). 
• Jet wash slides with distilled water and rinse with distilled water in a staining jar for five (5) 
minutes. 
• Rinse slides in 0.05M TBS pH7.2 in staining jar for five (5) minutes. 
• Dry around section and add normal horse serum (NHS) 1:20 to slides in a moisture chamber 
(completely cover the section) for twenty (20) minutes at room temperature (R.T.) (18°C- 20°C).  
• Blot excess serum. (Do not rinse). 
• Add approximately 100µl anti-insulin (M) 1:10 000 to sections in moisture chamber and 
incubate at 4ºC overnight. 
• Allow slides to reach room temperature. 
• Jet wash with 0.05M TBS pH7.2 and rinse in staining jar in 0.05M TBS pH7.2 for five (5) 
minutes.  
• Dry around sections and add 100µl Rabbit/Mouse (LINK) to slides in moisture chamber for 
thirty (30) minutes at room temperature (R.T.) (18°C- 20°C). 
• Jet wash with 0.05M TBS pH7.2 and rinse in staining jar in 0.05M TBS pH7.2 for ten (10) 
minutes. 
• Dry around sections and add 100ul AP Enzyme (ENHANCER) to slides in moisture chamber 
thirty (30) minutes at room temperature (R.T.) (18°C- 20°C).  
• Jet wash slides with 0.05M TBS pH 7.2 and rinse for ten (10) minutes in 0.05M TBS  
   PH7.2 in staining jar. 
• Dry around sections and add Substrate Working Solution to slides on a rack for three - five 
(3-5) 
Minutes at room temperature (R.T.) (18°C- 20°C). (Check progress under microscope). 
• Jet wash slides with distilled water and rinse in distilled water in staining jar for five (5) 
minutes. 
• Counterstain with haematoxylin for 2-4 minutes. 
• Rinse well in tap water. 
• Leave to “blue” in tap water for thirty (30) minutes. 
• Dry completely on paper towel (sections facing upwards). 
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• Mount slides in DPX. 
 
Quality control: 
 Method Control slides are included to monitor any non-specific staining. 
 Pipettes are serviced annually or more often as required.  
 
Appendix H: Immunohistochemistry protocol – Leptin 
 
Table 15 IHC stain protocol procedure, LEICA Bond Max protocol F 
Step Type Incubation 
Time 
Temperature Dispense Type 
1 Peroxide Block 5 min Ambient selected vol. 
2 Bond Wash Solution 0 min Ambient selected vol. 
3 Bond Wash Solution 0 min Ambient open 
4 Bond Wash Solution 0 min Ambient selected vol. 
5 Primary Antibody 15 min Ambient selected vol. 
6 Bond Wash Solution 0 min Ambient selected vol. 
7 Bond Wash Solution 0 min Ambient selected vol. 
8 Bond Wash Solution 0 min Ambient selected vol. 
9 Post Primary 8 min Ambient selected vol. 
10 Bond Wash Solution 2 min Ambient selected vol. 
11 Bond Wash Solution 2 min Ambient selected vol. 
12 Bond Wash Solution 2 min Ambient selected vol. 
13 Polymer 8 min Ambient selected vol. 
14 Bond Wash Solution 2 min Ambient selected vol. 
15 Bond Wash Solution 2 min Ambient selected vol. 
16 Deionized Water 0 min Ambient selected vol. 
17 Deionized Water 0 min Ambient selected vol. 
18 Mixed DAB Refine 10 min Ambient selected vol. 
19 Deionized Water 0 min Ambient selected vol. 
20 Deionized Water 0 min Ambient selected vol. 
21 Deionized Water 0 min Ambient selected vol. 
22 Haematoxylin 5min Ambient selected vol. 
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23 Deionized Water 0 min Ambient selected vol. 
24 Deionized Water 0 min Ambient selected vol. 
25 Deionized Water 0 min Ambient selected vol. 
 
Table 16: Manual rehydration procedure 
Step Solution Time Repetitions 
1 Ethanol (70%) 5 dips 1 
2 Ethanol (96%) 5 dips 1 
3 Ethanol (99%) 5 dips 1 
4 Xylene 1 min 2 
 
Table 17: Antibody information 
Antibody Source Antibody ID Clonality Raised Dilution 
Anti-Leptin Abcam Ab117751 Polyclonal Rabbit 1:50 
 
 
Appendix I: Morphometric analysis equipment 
 Nikon Eclipse Ti-S with PRIOR ProScan III. NIS Elements AR4.40 ©1991-2015 
 Leica QWin V3 software (Germany) 
 Zeiss Axioskop2, serial number 801452 (Carl Zeiss, AG, Oberkochen, Germany) 
 AxioVisio, version 4.7.2.0 (Carl Zeiss, AG, Oberkochen, Germany) 
 ZEN Lite 2012 (blue edition, version 1.1.2.0 (Carl Zeiss Microscopy GmbH) 
 
Appendix J Pathology grading criteria 
Grade 0 (absent): No pathological changes seen on the entire tissue section 
Grade I (mild): Present in <25% of tissue section 
Grade II (moderate): Present in 25-50% of tissue sections 
Grade III (severe): Present in >50% of tissue section 
 
Appendix K: Pancreas data 
Table 18 Number of islets per animal 
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Rot Treatment 
Islet 
Number 
256/15 C/ART- 4 
276/15 C/ART- 34 
285/14 C/ART- 8 
331/15 C/ART- 15 
372/15 C/ART- 20 
402/15 C/ART- 23 
419/15 C/ART- 32 
433/15 C/ART- 27 
474/14 C/ART- 32 
492/14 C/ART- 30 
266/15 C/ART+ 20 
267/14 C/ART+ 14 
281/15 C/ART+ 42 
303/14 C/ART+ 26 
339/14 C/ART+ 68 
361/15 C/ART+ 63 
409/15 C/ART+ 12 
429/15 C/ART+ 13 
444/15 C/ART+ 25 
474/15 C/ART+ 23 
261/15 HCD/ART- 18 
276/14 HCD/ART- 52 
312/14 HCD/ART- 61 
336/15 HCD/ART- 54 
382/15 HCD/ART- 11 
397/15 HCD/ART- 42 
424/15 HCD/ART- 78 
438/15 HCD/ART- 9 
479/15 HCD/ART- 11 
483/14 HCD/ART- 9 
258/14 HCD/ART+ 63 
271/15 HCD/ART+ 62 
286/15 HCD/ART+ 65 
294/14 HCD/ART+ 36 
366/15 HCD/ART+ 38 
377/15 HCD/ART+ 26 
402/14 HCD/ART+ 41 
414/15 HCD/ART+ 20 
484/15 HCD/ART+ 32 
644/15 HCD/ART+ 71 
 
Table 19 LSD post-hoc test of pancreatic islets area compared between the four groups. 
P-value, mean and standard error of islet area are indicated between the four groups. 
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Comparisons 
Cell {#1}-{#2} 
LSD test; variable Area (Spreadsheet in Surface and islet area.stw) Simultaneous confidence 
intervals Effect: Treatment Include condition: Islet="Islet Area" 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
{1}-{2} 
 
C/ART- C/ART+ 743,25 1447,27 0,61 
{1}-{3} 
 
C/ART- HCD/ART- -717,60 1442,58 0,62 
{1}-{4} 
 
C/ART- HCD/ART+ -696,51 1376,42 0,62 
{2}-{3} 
 
C/ART+ HCD/ART- -1460,85 1398,66 0,30 
{2}-{4} 
 
C/ART+ HCD/ART+ -1439,76 1330,31 0,29 
{3}-{4} 
 
HCD/ART- HCD/ART+ 21,09 1325,21 0,99 
 
Table 20 LSD post-hoc test of alpha- and beta-cell area p-values compared between the 
four groups. Values in red indicates all significant differences (p<0.05). 
 
Comparisons Cell 
{#1}-{#2} 
LSD test; variable Area (Spreadsheet in Surface and islet area.stw) Simultaneous 
confidence intervals Effect: Treatment*Islet 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
{1}-{2} 
 
C/ART-*A Cell Area C/ART-*B Cell Area -2315,61 361,66 0,00 
{1}-{3} 
 
C/ART-*A Cell Area C/ART+*A Cell Area 20,88 387,37 0,96 
{1}-{4} 
 
C/ART-*A Cell Area C/ART+*B Cell Area -1627,57 387,37 0,00 
{1}-{5} 
 
C/ART-*A Cell Area HCD/ART-*A Cell Area -253,70 386,04 0,52 
{1}-{6} 
 
C/ART-*A Cell Area HCD/ART-*B Cell Area -2112,16 386,04 0,00 
{1}-{7} 
 
C/ART-*A Cell Area HCD/ART+*A Cell Area 14,25 368,64 0,97 
{1}-{8} 
 
C/ART-*A Cell Area HCD/ART+*B Cell Area -2032,71 368,64 0,00 
{2}-{3} 
 
C/ART-*B Cell Area C/ART+*A Cell Area 2336,48 387,37 0,00 
{2}-{4} 
 
C/ART-*B Cell Area C/ART+*B Cell Area 688,04 387,37 0,08 
{2}-{5} 
 
C/ART-*B Cell Area HCD/ART-*A Cell Area 2061,91 386,04 0,00 
{2}-{6} 
 
C/ART-*B Cell Area HCD/ART-*B Cell Area 203,45 386,04 0,60 
{2}-{7} 
 
C/ART-*B Cell Area HCD/ART+*A Cell Area 2329,85 368,64 0,00 
{2}-{8} 
 
C/ART-*B Cell Area HCD/ART+*B Cell Area 282,90 368,64 0,45 
{3}-{4} 
 
C/ART+*A Cell Area C/ART+*B Cell Area -1648,44 336,30 0,00 
{3}-{5} 
 
C/ART+*A Cell Area HCD/ART-*A Cell Area -274,58 374,19 0,47 
{3}-{6} 
 
C/ART+*A Cell Area HCD/ART-*B Cell Area -2133,04 374,19 0,00 
{3}-{7} 
 
C/ART+*A Cell Area HCD/ART+*A Cell Area -6,63 356,22 0,99 
{3}-{8} 
 
C/ART+*A Cell Area HCD/ART+*B Cell Area -2053,58 356,22 0,00 
{4}-{5} 
 
C/ART+*B Cell Area HCD/ART-*A Cell Area 1373,87 374,19 0,00 
{4}-{6} 
 
C/ART+*B Cell Area HCD/ART-*B Cell Area -484,59 374,19 0,20 
{4}-{7} 
 
C/ART+*B Cell Area HCD/ART+*A Cell Area 1641,81 356,22 0,00 
{4}-{8} 
 
C/ART+*B Cell Area HCD/ART+*B Cell Area -405,14 356,22 0,26 
{5}-{6} 
 
HCD/ART-*A Cell Area HCD/ART-*B Cell Area -1858,46 330,71 0,00 
{5}-{7} 
 
HCD/ART-*A Cell Area HCD/ART+*A Cell Area 267,95 354,77 0,46 
{5}-{8} 
 
HCD/ART-*A Cell Area HCD/ART+*B Cell Area -1779,01 354,77 0,00 
{6}-{7} 
 
HCD/ART-*B Cell Area HCD/ART+*A Cell Area 2126,41 354,77 0,00 
{6}-{8} 
 
HCD/ART-*B Cell Area HCD/ART+*B Cell Area 79,45 354,77 0,82 
{7}-{8} 
 
HCD/ART+*A Cell Area HCD/ART+*B Cell Area -2046,95 293,99 0,00 
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Table 21 LSD post-hoc test of the number of islets per section area compared between the 
four groups. Significant differences between groups will be indicated in red. If no 
significant differences are seen between the four groups no red values will appear. 
 
Cell 
No. 
LSD test; variable #isletspermm^2 (Spreadsheet in Surface and islet area.stw) Probabilities for Post Hoc 
Tests Error: Between MS = .37844, df = 36.000 
Treatment 
 
{1} 
1.1025 
 
{2} 
1.0175 
 
{3} 
1.5078 
 
{4} 
1.5521 
 
1 
 
C/ART-  0,759090 0,149358 0,110877 
2 
 
C/ART+ 0,759090  0,083132 0,059807 
3 
 
HCD/ART- 0,149358 0,083132  0,872870 
4 
 
HCD/ART+ 0,110877 0,059807 0,872870  
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Table 22 Pathology changes seen within each pancreas sample. Pathology was classified as follows; absent (0), mild (1), moderate (2) and 
severe (3).  
Rat Treatment Absent/Present Pathology  Comments 
      
Eosinophilic 
 duct  
258/14 HCD/ART+ 0 0  
429/14 C/ART- 0 0  
474/14 C/ART- 0 0  
267/14 C/ART+ 0 0  
339/14 C/ART+ 1 1 
Some collecting ducts contain eosinophilic 
proteinaceous material and are mildly dilated 
276/14 HCD/ART- 0 0  
312/14 HCD/ART- 0 0  
483/14 HCD/ART- 0 0  
402/14 HCD/ART+ 0 0 Microvesicular space 
294/14 HCD/ART+ 0 0 Microvesicular space 
258/15 C/ART- 0 0 Microvesicular space 
256/15 C/ART- 0 0  
281/15 C/ART+ 0 0 Microvesicular space 
377/15 HCD/ART+ 0 0  
366/15 HCD/ART+ 0 0  
414/15 HCD/ART+ 0 0  
438/15 HCD/ART- 0 0 Some fat cells outside of pancreas tissue 
419/15 C/ART- 0 0 One islet had a built up of nuclei  
433/15 C/ART- 0 0  
429/15 C/ART+ 0 0  
474/15 C/ART+ 0 0  
479/15 HCD/ART- 0 0  
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261/15 HCD/ART- 0 0  
303/14 C/ART+ 0 0  
331/15 C/ART- 0 0  
276/15 C/ART- 0 0  
372/15 C/ART- 0 0  
402/15 C/ART- 0 0  
444/15 C/ART+ 0 0  
361/15 C/ART+ 0 0  
266/15 C/ART+ 0 0  
409/15 C/ART+ 0 0  
336/15 HCD/ART- 0 0  
424/15 HCD/ART- 1 1 
Some collecting ducts contain eosinophilic 
proteinaceous material and are mildly dilated.  
397/15 HCD/ART- 0 0  
382/15 HCD/ART- 0 0  
644/15 HCD/ART+ 0 0  
484/15 HCD/ART+ 0 0  
271/15 HCD/ART+ 0 0  
286/15 HCD/ART+ 0  0   
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Appendix L: Kidney data 
 
Corpuscle: 
Treatment; LS Means
Current ef f ect: F(3, 36)=1.0259, p=.39261
Ty pe III decomposition
Vertical bars denote 0.95 conf idence interv als
Include condition:  Ty pe="Corpsucle"
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Figure 0.1 Average corpuscle area (μm²) between the four groups. No significant 
differences were seen between the four groups (p>0.392). 
 
Treatment; LS Means
Current ef f ect: F(3, 36)=1.0623, p=.37718
Ty pe III decomposition
Vertical bars denote 0.95 conf idence interv als
Include condition:  Ty pe="Corpsucle"
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Figure 0.2 Average corpuscle diameter (μm) between the four groups. No significant 
differences were seen between the four groups (p>0.377) 
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Treatment; LS Means
Current ef f ect: F(3, 36)=1.1252, p=.35175
Ty pe III decomposition
Vertical bars denote 0.95 conf idence interv als
Include condition:  Ty pe="Corpsucle"
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Figure 0.3 Average corpuscle perimeter (μm) between the four groups. No significant 
differences were seen between the four groups (p>0.351). 
 
Glomeruli: 
Treatment; LS Means
Current ef f ect: F(3, 36)=1.0776, p=.37085
Ty pe III decomposition
Vertical bars denote 0.95 conf idence interv als
Include condition:  Ty pe="Glomerulus"
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Figure 0.4 Average glomeruli area (μm²) between the four treatment groups. No 
significant differences were seen between the four groups (p>0.371). 
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Treatment; LS Means
Current ef f ect: F(3, 36)=1.1108, p=.35743
Ty pe III decomposition
Vertical bars denote 0.95 conf idence interv als
Include condition:  Ty pe="Glomerulus"
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Figure 0.5 Average glomeruli diameter (μm) between the four treatment groups. No 
significant differences were seen between the four groups (p>0.357). 
 
Treatment; LS Means
Current ef f ect: F(3, 36)=.81369, p=.49473
Ty pe III decomposition
Vertical bars denote 0.95 conf idence interv als
Include condition:  Ty pe="Glomerulus"
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Figure 0.6 Average glomeruli perimeter (μm) between the four treatment groups. No 
significant differences were seen between the four groups (p>0.494). 
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Treatment; LS Means
Current ef f ect: F(3, 36)=.92799, p=.43715
Ty pe III decomposition
Vertical bars denote 0.95 conf idence interv als
Include condition:  Ty pe="Glomerulus"
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Figure 0.7 Average renal space area (μm²) between the four treatment groups. No 
significant differences were seen between the four groups (p>0.437). 
 
Arcuate arteries: 
 
Treatment; LS Means
Current ef f ect: F(3, 32)=.97312, p=.41752
Ty pe III decomposition
Vertical bars denote 0.95 conf idence interv als
Include condition: V4="Lumen"
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Figure 0.8 Average lumen diameter (μm) between the four treatment groups. No 
significant differences were seen between the four groups (p>0.417). 
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Treatment; LS Means
Current ef f ect: F(3, 32)=.26445, p=.85049
Ty pe III decomposition
Vertical bars denote 0.95 conf idence interv als
Include condition: V4="Media"
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Figure 0.9 Average tunica media thickness (μm) between the four treatment groups. No 
significant differences were seen between the four groups (p>0.85). 
 
Treatment; LS Means
Current ef f ect: F(3, 32)=.42583, p=.73582
Ty pe III decomposition
Vertical bars denote 0.95 conf idence interv als
Include condition: V4="Adv entita"
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Figure 0.10 Average tunica adventitia thickness (μm) between the four treatment 
groups. No significant differences were seen between the four groups (p>0.735). 
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Table 23 Pathology changes seen within all kidney samples. Pathology was classified as follows; absent (0), mild (1), moderate (2) and 
severe (3).  
Rat Treatment Absent/Present Pathology  
   Vacuolisation  Swelling Eosinophilia Basophilic 
Dilation of 
perivascular 
spaces  
630/15 HCD/ART+ 1 2 0 0 0 0  
555/15 C/ART- 0 0 0 0 0 0  
480/15 HCD/ART- 1 1 0 0 0 1 Mild dilation of perivascular spaces associated with the larger cortical blood vessels. Few proximal convoluted tubular epithelial cells show mild vacuolisation of the cytoplasm 
475/15 C/ART+ 1 2 0 0 0 0  
425/15 HCD/ART- 0 0 0 0 0 0  
420/15 C/ART- 1 0 0 0 0 1 Mild dilation of perivascular spaces associated with the larger cortical blood vessels. Few proximal convoluted tubular epithelial cells show mild vacuolisation of the cytoplasm 
445/15 C/ART+ 1 0 0 0 0 1 Mild dilation of perivascular spaces associated with the larger cortical blood vessels. Few proximal convoluted tubular epithelial cells show mild vacuolisation of the cytoplasm 
440/15 HCD/ART- 1 1 0 0 0 0  
403/15 C/ART- 1 1 0 0 0 0  
470/15 C/ART- 1 1 0 0 1 0 Few proximal convoluted tubular structures contain scant basophilic material in the lumen. Single tubular epithelial cells of the proximal convoluted tubules are mildly vacuolated only. 
398/15 HCD/ART- 1 2 0 0 0 0  
415/15 HCD/ART+ 1 1 0 0 1 0 Few proximal convoluted tubular structures contain scant basophilic material in the lumen. Single tubular epithelial cells of the proximal convoluted tubules are mildly vacuolated only. 
378/14/15 HCD/ART+ 0 0 0 0 0 0  
373/15 C/ART- 1 2 0 0 1 0 Few proximal convoluted tubular structures contain scant basophilic material in the lumen? 
367/15 HCD/ART+ 1 2 0 0 0 0  
635/15 C/ART+ 1 1 0 0 0 0  
362/15 C/ART+ 1 1 0 0 0 0  
645/15 HCD/ART+ 0 0 0 0 0 0  
640/15 C/ART+ 1 1 0 0 0 0  
332/15 C/ART- 1 1 0 0 0 0 Few proximal convoluted tubular epithelial cells show mild vacuolisation of the cytoplasm 
684/15 C/ART+ 1 1 0 0 0 0  
689/15 HCD/ART+ 1 1 0 0 0 0 Few proximal convoluted tubular epithelial cells show mild vacuolisation of the cytoplasm 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 81 
 
708/14 HCD/ART+ 1 1 0 0 0 0  
782/14 HCD/ART- 1 1 0 0 1 0 Few proximal convoluted tubular structures contain scant basophilic material in the lumen? 
257/15 C/ART- 1 0 0 0 0 1 Mild dilation of perivascular spaces associated with the larger cortical blood vessels. Few proximal convoluted tubular epithelial cells show mild vacuolisation of the cytoplasm 
277/15 C/ART- 1 1 0 0 1 0 Single cortical tubules show scant basophilic material in tubular lumens and some proximal convoluted tubular epithelial cells within the cortical region are mildly vacuolated. 
435/15 C/ART- 1 1 0 0 0 0 Mild multifocal vacuolisation of proximal convoluted tubular epithelial cells 
655/15 C/ART- 1 1 0 0 0 0 Mild multifocal vacuolisation of proximal convoluted tubular epithelial cells.  
430/15 C/ART+ 1 1 0 0 0 0 Mild multifocal vacuolisation of proximal convoluted tubular epithelial cells 
282/15 C/ART+ 1 1 0 0 1 0 Few proximal convoluted tubular structures contain scant basophilic material in the lumen. Single tubular epithelial cells of the proximal convoluted tubules are mildly vacuolated only. 
267/15 C/ART+ 1 1 0 0 0 0  
410/15 C/ART+ 0 0 0 0 0 0  
337/15 HCD/ART- 1 1 1 0 1 0 Multifocal mild vacuolated appearance of proximal convoluted tubular epithelial cells that in areas appear mildly swollen. The few of these tubules also contain basophilic material in the lumen. 
262/15 HCD/ART- 1 1 1 0 1 0 Multifocal scattered proximal convoluted tubular epithelial cells appear mildly swollen and vacuolated single tubules also contain basophilic material.  
650/15 HCD/ART- 1 1 1 0 0 0 Multifocal scattered few (minimal) proximal convoluted tubular epithelial cells appear mildly swollen and vacuolated 
383/15 HCD/ART- 1 1 1 0 0 0 Multifocal scattered few (minimal) proximal convoluted tubular epithelial cells appear mildly swollen and vacuolated. Single cells contain yellow and pigment suggestive of bile pigment in the cytoplasm.   
703/15 HCD/ART+ 0 0 0 0 0 0  
485/15 HCD/ART+ 0 0 0 0 0 0  
272/15 HCD/ART+ 0 0 0 0 0 0  
287/15 HCD/ART+ 1 1 1 1 0 0 Single cells appear slightly swollen with mildly increased eosinophilia of the cytoplasm and in few also single vacuolar structures.  
 
 
Appendix M: Liver data 
Table 24 Pathology changes seen within all liver samples. Pathology was classified as follows; absent (0), mild (1), moderate (2) and 
severe (3).  
Rat Treatment Absent/Present Pathology   
   
Granular 
appearance Vacuolisation 
Fatty 
change  
379/14 C/ART+ 1 0 0 1 More than 1, but less than 2 
660/14 HCD/ART+ 0 0 0 0  
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620/14 HCD/ART+ 1 1 0 0 Autolysis, artifactual changes  
690/14 HCD/ART+ 1 1 1 0 Mild granular appearance and vacuolisation 
361/14 C/ART+ 1 1 0 0  
442/14 C/ART+ 1 0 2 1 less than 1 
469/14 HCD/ART- 1 1 0 0  
433/14 C/ART- 1 2 2 0  
478/14 C/ART- 0 0 0 0 Artifact, eosin crystals, small focus of inflammatory infiltrate, query necrosis 
487/14 HCD/ART- 1 2 1 0 Mild Granular appearance  
406/14 HCD/ART+ 1 1 0 0 Mild Granular appearance  
460/14 C/ART+ 1 1 1 0 Mild Granular appearance  
496/14 C/ART- 1 1 1 1 Mild Granular appearance, with autolysis, mild vac in some areas, less than 1 fc 
424/14 HCD/ART- 1 1 1 0 Mild gran app diffuse, vac in some area 
540/14 HCD/ART+ 1 2 1 0 Moderate granular appearance in some areas, mild vac in some areas 
560/14 HCD/ART- 1 1 1 0 Mild gran app, with autolysis, vac 
590/14 C/ART+ 1 1 0 0 mild gran app, with autolysis 
520/14 HCD/ART- 1 1 1 0 Mild gran app (not in central areas) 
580/14 HCD/ART+ 1 1 0 0 Mild gran app, some connective tissue found 
570/14 C/ART- 1 1 1 0 mild gran app, mild vac in some cells 
630/14 C/ART+ 0 0 0 0  
530/14 C/ART- 1 1 1 1 mild gran appearance, vac, less than 1 fc 
343/14 C/ART+ 0 0 0 0 Query vac 
242/14 HCD/ART- 1 1 1 1 mild gran appearance, vac, less than 1 fatty change 
251/14 C/ART- 1 1 0 0 
Few areas show centrilobular hepatocytes with mildly increased granular appearance of the cytoplasm and few vacuoles present. Mild hydropic degeneration 
evident in few of these cells, few are also swollen. 
397/14 C/ART- 1 1 0 0 Hepatocytes have a slightly granular cytoplasm diffusely throughout the section. 
325/14 C/ART- 1 2 1 0  
289/14 C/ART- 1 2 0 0 
Moderate granular appearance of the cytoplasm of hepatocytes in the centrilobular regions. Few lobules reveal the presence of single hepatocytes immediately 
adjacent to the centrilobular zones that show the presence of single large fat vacuoles (fatty change).  
307/14 C/ART+ 1 2 0 0 Moderately granular appearance of the hepatocyte cytoplasm’s, appearing more prominent in the centrilobular and midzonal regions but diffusely present.  
421/14 C/ART+ 1 1 0 0 Hepatocytes show mildly granular cytoplasm diffusely  
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271/14 C/ART+ 1 1 0 0 Slight granularity of hepatocyte cytoplasm diffuse 
415/14 C/ART+ 0 0 0 0  
280/14 HCD/ART- 1 2 0 0 Moderately granular appearance of the hepatocyte cytoplasm, appearing more prominent in the centrilobular and midzonal regions but diffusely present 
388/14 HCD/ART- 1 1 0 0 Mild granularity of the cytoplasm of hepatocytes diffusely  
352/14 HCD/ART- 0 0 0 0 Congested 
316/14 HCD/ART- 0 0 0 0  
262/14 HCD/ART+ 1 1 0 0 Mild diffuse granularity of the hepatocyte cytoplasm.  
298/14 HCD/ART+ 1 1 0 0 Hepatocyte cytoplasm are diffusely mildly granular in appearance.  
370/14 HCD/ART+ 1 0 1 0 
Scattered hepatocytes in the centrilobular areas show mild vacuolar change consisting of single larger vacuoles or smaller multiple vacuoles indicative of mild fatty 
change. Scattered single Ito cells in these areas are also vacuolated 
334/14 HCD/ART+ 1 0 0 1 Less than 1 fc 
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Appendix N: Leptin Section of thesis published Acta Hitochemica 
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